Processing 00000000.tx.1: Amelioration of Diabetes in Nonobese Diabetic Mice with Advanced Disease by Linomide-Induced Immunoregulation Combined with Reg Protein Treatment1 David J. 

Phrase: "Amelioration of Diabetes"

Phrase: "in Nonobese Diabetic Mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0241863:DIABETIC [Finding]

Phrase: "with Advanced Disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "by Linomide-Induced Immunoregulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678889:Immunoregulation [Organism Function]

Phrase: "Combined with Reg Protein Treatment1 David J."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0205195:Combined [Qualitative Concept]
   748   C1419333:REG [Gene or Genome]
   748   C1705631:REG [Gene or Genome]
   714 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.2: Gross, Lola Weiss, Israel Reibstein, Joop van den Brand, Hiroshi Okamoto, Anne Clark and Shimon Slavin Departments of Endocrinology and Metabolism (D.J.G.,), Bone Marrow Transplantation and Cancer Immunobiology Laboratory (L.W., I.R., S.S.), Hebrew University-Hadassah Medical Center, Jerusalem 91120, Israel; 

Phrase: "Gross, Lola Weiss,"

Phrase: "Israel Reibstein,"

Phrase: "Joop van den Brand,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0178587:DEN [Quantitative Concept]
   812   C0557775:Van [Manufactured Object]
   812   C0645690:BrAnd [Pharmacologic Substance,Steroid]

Phrase: "Hiroshi Okamoto,"

Phrase: "Anne Clark"

Phrase: "and"

Phrase: "Shimon Slavin Departments of Endocrinology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C0587463:Endocrinology department [Health Care Related Organization]
   726   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "(D.J.G.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0439417:d g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Bone Marrow Transplantation"
Meta Candidates (Total=19; Excluded=5; Pruned=0; Remaining=14)
  1000   C0005961:Bone Marrow Transplantation [Therapeutic or Preventive Procedure]
           Marrow Transplantation
   913   C0005976:Bone Transplantation [Therapeutic or Preventive Procedure]
   901   C0005953:Bone Marrow [Tissue]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: "and"

Phrase: "Cancer Immunobiology Laboratory"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022877:Laboratory [Manufactured Object,Organization]
   827   C3244292:laboratory [Functional Concept]

Phrase: "(L.W., I.R., S.S."

Phrase: ")"

Phrase: ","

Phrase: "Hebrew University-Hadassah Medical Center,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   888   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   840   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   840   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   804   C0205099:Center [Spatial Concept]
   804   C0205476:Medical [Functional Concept]

Phrase: "Jerusalem 91120,"

Phrase: "Israel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]

Phrase: ";"
Processing 00000000.tx.3: the Oxford Diabetes Research Laboratories, Radcliffe Infirmary (J.v.d.B., A.C.), Oxford, United Kingdom OX2 6HE; 

Phrase: "the Oxford Diabetes Research Laboratories,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0022886:research laboratory [Research Activity]
   812   C0022877:Laboratories [Manufactured Object,Organization]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1619828:Laboratories [Intellectual Product]
   779 E C3244292:laboratory [Functional Concept]

Phrase: "Radcliffe Infirmary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0221502:infirmary [Health Care Related Organization]

Phrase: "(J.v.d.B.,"

Phrase: "A.C."

Phrase: ")"

Phrase: ","

Phrase: "Oxford,"

Phrase: "United Kingdom OX2 6HE"

Phrase: ";"
Processing 00000000.tx.4: and the Department of Biochemistry, Tohoku University School of Medicine (H.O.), Sendai 9877, Japan Address all correspondence and requests for reprints to: David J. 

Phrase: "and"

Phrase: "the Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "Tohoku University School of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "(H.O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0455483:H/O: * NOS [Finding]

Phrase: ")"

Phrase: ","

Phrase: "Sendai 9877,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "David J."
Processing 00000000.tx.5: Gross, M.D., Department of Endocrinology and Metabolism, Hadassah University Hospital, Jerusalem 91120, Israel. 

Phrase: "Gross, M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1512018:M.D. [Intellectual Product]
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Department of Endocrinology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587463:Endocrinology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025519:Metabolism [Organism Function]
  1000   C0025520:metabolism [Functional Concept]

Phrase: "Hadassah University Hospital,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0020028:university hospital [Health Care Related Organization,Manufactured Object]
   827   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1510665:Hospital [Qualitative Concept]
   743 E C1609061:Hospitals [Intellectual Product]

Phrase: "Jerusalem 91120,"

Phrase: "Israel."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022271:Israel [Geographic Area]
Processing 00000000.tx.6: E-mail: gross{at}vms.huji.ac.il  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Oral linomide, (quinoline-3-carboxamide), has been shown to prevent autoimmune insulitis, islet destruction, and diabetes in NOD mice treated at an early stage of the disease, but confers only partial protection in animals with advanced disease. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "gross{at}vms.huji.ac.il  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oral linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "(quinoline-3-carboxamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2716460:quinoline-3-carboxamide [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "autoimmune insulitis,"

Phrase: "islet destruction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1261381:Destruction [Therapeutic or Preventive Procedure]
   861   C1948029:Destruction [Activity]

Phrase: "and"

Phrase: "diabetes in NOD mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]

Phrase: "treated at an early stage of the disease,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C1517886:Early Stage [Classification]
   770   C2363430:Early stage [Temporal Concept]
   767   C0679245:early disease [Temporal Concept]
   767   C0699749:disease stage [Diagnostic Procedure]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0205390:Stage [Temporal Concept]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C1279919:Early [Temporal Concept]
   744   C1300072:Stage [Clinical Attribute]
   744   C1306673:Stage [Qualitative Concept]
   744   C1522326:Treated [Functional Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "but"

Phrase: "confers"

Phrase: "only partial protection in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "with advanced disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.7: Reg protein, the gene product of a complementary DNA isolated from a regenerating rat islet library, has been previously shown to induce expansion of -cell mass in pancreatectomized rats. 

Phrase: "Reg protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the gene product of a complementary DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0017337:Gene [Gene or Genome]
   748   C1514468:product [Entity]
   748   C1704444:Product [Quantitative Concept]

Phrase: "isolated from a regenerating rat islet library,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   748   C0023621:Library [Manufactured Object,Organization]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0205409:Isolated [Functional Concept]
   748   C0334213:regenerating [Functional Concept]
   748   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0872147:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expansion of -cell mass in pancreatectomized rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.8: To determine the effect of treatment combining immunomodulation and Reg protein on advanced autoimmune diabetes, we treated female NOD mice with oral linomide and ip Reg protein injections. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effect of treatment combining immunomodulation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1518681:Treatment Effect [Finding]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "Reg protein on advanced autoimmune diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "female NOD mice with oral linomide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0085243:Mice, NOD [Mammal]
           NOD
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0751781:NOD [Disease or Syndrome]

Phrase: "and"

Phrase: "ip Reg protein injections."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   886   C0021493:IP injection [Therapeutic or Preventive Procedure]
   812   C0021485:injections [Therapeutic or Preventive Procedure]
   812   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   812   C1828121:Injections [Functional Concept]
   779 E C1272883:Injection [Biomedical or Dental Material]
Processing 00000000.tx.9: In 14-week-old animals with less severe disease (glucose tolerant), treatment with each agent alone resulted in amelioration of diabetes, as did treatment with Reg alone in 5-week-old prediabetic mice. 

Phrase: "In 14-week-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "with less severe disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "tolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231198:Tolerant [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "treatment with each agent"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "resulted in amelioration of diabetes,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "as"

Phrase: "did"

Phrase: "treatment with Reg"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "alone in 5-week-old prediabetic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205171:Alone [Quantitative Concept]
   748   C0439044:alone [Finding]
   748   C0679994:alone [Group Attribute]
Processing 00000000.tx.10: In 14-week-old animals with more severe disease (glucose intolerant), only treatment with the combination of both agents, but not that with each separately, resulted in amelioration of diabetes. 

Phrase: "In 14-week-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "with more severe disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(glucose intolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231200:Intolerant [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "only treatment with the combination of both agents,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "that with each separately,"

Phrase: "resulted in amelioration of diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.11: Our study suggests that treatment aimed at abrogation of autoimmunity combined with expansion of -cell mass constitutes a potential therapeutic approach for treatment of insulin-dependent diabetes mellitus.  

Phrase: "Our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "aimed at abrogation of autoimmunity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0004368:Autoimmunity [Pathologic Function]
   726   C1947946:Aim [Idea or Concept]
   726   C2948600:Aim [Pharmacologic Substance]
   726   C3540471:AIM [Gene or Genome]
   726   C3540472:AIM [Functional Concept]

Phrase: "combined with expansion of -cell mass"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0007595:cell expansion [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0205195:Combined [Qualitative Concept]
   753   C0577559:Mass [Finding]
   753   C1269647:Cell [Cell]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3152252:Mass [Quantitative Concept]
   719 E C0336789:Combine [Manufactured Object]

Phrase: "constitutes"

Phrase: "a potential therapeutic approach for treatment of insulin-dependent diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.12: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  INSULIN-DEPENDENT diabetes mellitus (IDDM) is a chronic autoimmune disease in which progressive destruction of pancreatic -cells eventually culminates in hyperglycemia due to the inability of the reduced -cell mass to meet the normal secretory demand for insulin. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "INSULIN-DEPENDENT diabetes mellitus (IDDM)"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "a chronic autoimmune disease in which progressive destruction of pancreatic -cells eventually"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0004364:Autoimmune Disease [Disease or Syndrome]
   751   C0008679:Chronic disease [Disease or Syndrome]
   751   C0030286:Pancreatic disease NOS [Disease or Syndrome]
   751   C0677932:progressive disease [Neoplastic Process]
   751   C1335499:Progressive Disease [Finding]
   751   C3539781:Progressive Disease [Disease or Syndrome]
   736   C0012634:Disease [Disease or Syndrome]
   736   C0443146:Autoimmune [Pathologic Function]

Phrase: "culminates in hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "due to the inability"

Phrase: "of the reduced -cell mass to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "meet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Meet [Idea or Concept]

Phrase: "the normal secretory demand for insulin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441516:Demand [Therapeutic or Preventive Procedure]
   753   C0699784:demand [Idea or Concept]
Processing 00000000.tx.13: Until recently, -cells have been regarded as a passive player in this pathogenetic scenario of IDDM. 

Phrase: "Until"

Phrase: "recently, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "regarded as a passive player"

Phrase: "in this pathogenetic scenario"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683579:scenario [Functional Concept]

Phrase: "of IDDM."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.14: It is becoming increasingly clear, however, that the appearance of clinical diabetes is dependent on a balance between the destructive autoimmune process, on the one hand, and the capacity of the pancreas to expand the -cell mass, on the other. 

Phrase: "It"

Phrase: "is"

Phrase: "becoming"

Phrase: "increasingly"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "however,"

Phrase: "that"

Phrase: "the appearance of clinical diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0233426:Appearance [Organism Attribute]
   760   C0700364:Appearance [Qualitative Concept]

Phrase: "is"

Phrase: "dependent on a balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "between the destructive autoimmune process,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0443146:Autoimmune Process [Pathologic Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "on the one hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0018563:Hand [Body Part, Organ, or Organ Component]
   861   C1281583:Hand [Body Part, Organ, or Organ Component]
   861   C1552914:hand [Quantitative Concept]
   805 E C0024763:Manual [Intellectual Product,Manufactured Object]
   805 E C0175674:Manual [Functional Concept]

Phrase: "and"

Phrase: "the capacity of the pancreas to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "the -cell mass,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "on the"

Phrase: "other."
Processing 00000000.tx.15: Thus, it was shown many years ago that in the pancreases of patients with new-onset IDDM, neoformation of -cells occurs (1, 2, 3), a phenomenon also documented in animal models of diabetes with reduced -cell mass (4), in transgenic mice in which -interferon expression by the -cells induces lymphocytic infiltration and -cell damage (5), and in NOD (nonobese diabetic) mice (6, 7). 

Phrase: "Thus,"

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "many years ago"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "that in the pancreases of patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0030705:Patients [Patient or Disabled Group]
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "with new-onset IDDM,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "neoformation of -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "occurs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a phenomenon also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "documented in animal models of diabetes"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C3161035:Models [Intellectual Product]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]

Phrase: "with reduced -cell mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "(4"

Phrase: ")"

Phrase: ","

Phrase: "in transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "in which -interferon expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "by the -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "lymphocytic infiltration"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1262091:lymphocytic infiltration [Disease or Syndrome]
   861   C0024264:Lymphocytic [Cell]
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]
   861   C2939172:Lymphocytic [Qualitative Concept]

Phrase: "and -"

Phrase: "cell damage"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0599732:cell damage [Cell or Molecular Dysfunction]
   861   C0007634:Cell [Cell]
   861   C0010957:Damage [Injury or Poisoning]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1883709:Damage [Functional Concept]
   861   C1948049:Cell [Spatial Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and in NOD (nonobese diabetic) mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0085243:Non-Obese Diabetic Mice [Mammal]
           Mice, NOD
           NOD
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]
   753   C0241863:DIABETIC [Finding]
   753   C0751781:NOD [Disease or Syndrome]
   753   C1515981:And [Idea or Concept]

Phrase: "(6,"

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.16: Moreover, the fact that only a small minority of individuals with islet cell antibodies, an indicator of autoimmunity toward the -cell, proceed to develop diabetes (8, 9, 10) indicates that other factors, namely -cell function and capacity for proliferation and/or neoformation, might play a crucial role in the development of the disease. 

Phrase: "Moreover,"

Phrase: "the fact"

Phrase: "that only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small minority of individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026192:Minority [Population Group]

Phrase: "with islet cell antibodies,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   966   C0063900:islet cell antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   901   C1522529:Islet Cell [Cell]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0007634:Cell [Cell]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "an indicator of autoimmunity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   770   C1235732:Indicator [Bird]
   770   C1522602:Indicator [Functional Concept]

Phrase: "toward the -cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "proceed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(8,"

Phrase: "9,"

Phrase: "10"

Phrase: ")"

Phrase: "indicates"

Phrase: "that"

Phrase: "other factors,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "namely -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   901   C0007613:Cell Function [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1705273:Function [Intellectual Product]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "and"

Phrase: "capacity for proliferation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516240:Capacity [Quantitative Concept]

Phrase: "and/or"

Phrase: "neoformation,"

Phrase: "might"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a crucial role in the development of the disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.17: The lack of significant proliferative capacity of mature -cells constitutes a major impediment to the treatment of diabetes, illustrated by the low success rates of various immunomodulatory approaches in patients with newly diagnosed IDDM (11). 

Phrase: "The lack of significant proliferative capacity of mature -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332268:lack [Qualitative Concept]

Phrase: "constitutes"

Phrase: "a major impediment to the treatment of diabetes,"

Phrase: "illustrated by the low success rates of various immunomodulatory approaches"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   741   C0442415:Low approach [Spatial Concept]
   739   C0205251:low [Qualitative Concept]
   739   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   739   C0449445:Approaches [Spatial Concept]
   739   C0597535:Success [Social Behavior]
   739   C1292724:Approaches [Functional Concept]
   739   C1299352:Low [Qualitative Concept]
   739   C1550472:low [Idea or Concept]
   706   C0871208:Rate [Activity]
   706   C1521828:Rate [Quantitative Concept]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with newly diagnosed IDDM"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   901   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   885   C1320655:Newly diagnosed diabetes [Finding]
   827   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   799   C0011847:Diabetes [Disease or Syndrome]
   799   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C0851827:Dependent [Qualitative Concept]
   799   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   799   C1579433:Insulin [Pharmacologic Substance]
   799   C1701901:Dependent [Qualitative Concept]
   799   C3244310:dependent [Functional Concept]
   743 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   716 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.18: In this setting, the unsatisfactory outcome can be accounted for by the lack of a critical -cell mass necessary to maintain normoglycemia despite successful abrogation of the autoimmune process. 

Phrase: "In this setting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]

Phrase: "the unsatisfactory outcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1274040:Outcome [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by the lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "of a critical -cell mass necessary to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0577559:Mass [Finding]
   804   C1306372:*Mass [Quantitative Concept]
   804   C3152252:Mass [Quantitative Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "normoglycemia despite successful abrogation of the autoimmune process."
Processing 00000000.tx.19: We have previously shown that linomide, a novel immunomodulatory drug, prevents diabetes and insulitis in young female NOD, but only partially ameliorates diabetes in animals with advanced disease (12). 

Phrase: "We"

Phrase: "have"

Phrase: "previously"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "a novel immunomodulatory drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "and"

Phrase: "insulitis in young female NOD,"

Phrase: "but"

Phrase: "only partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "ameliorates"

Phrase: "diabetes in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "with advanced disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.20: In the latter condition, linomide can protect from diabetes, providing that the -cell mass is sufficiently augmented by islet isografting (13). 

Phrase: "In the latter condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0012634:condition [Disease or Syndrome]
   861   C0348080:Condition [Qualitative Concept]
   861   C1705253:Condition [Conceptual Entity]
   789 E C0009647:Conditioned [Mental Process]
   789 E C1701901:Conditional [Qualitative Concept]
   789 E C1963686:Conditional [Functional Concept]
   761 E C1519605:Conditionality [Conceptual Entity]

Phrase: "linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "can"

Phrase: "protect from diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "providing that"

Phrase: "the -cell mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "is"

Phrase: "sufficiently"

Phrase: "augmented by islet isografting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205217:Augmented [Quantitative Concept]
   770   C0520485:Isografting [Therapeutic or Preventive Procedure]
   737 E C0392763:Isograft [Tissue]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.21: In a recent study, Watanabe et al. demonstrate induction of -cell replication and amelioration of diabetes in pancreatectomized rats by Reg protein (14), Therefore, we reasoned that linomide treatment of female NOD with advanced disease combined with this alternative approach for -cell augmentation, Reg-induced -cell expansion, might result in an improved salvage rate from clinical diabetes in this model of autoimmune diabetes. 

Phrase: "In a recent study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "Watanabe et al."

Phrase: "demonstrate"

Phrase: "induction of -cell replication"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0007590:cell replication [Cell Function]
   812   C0598312:Replication [Genetic Function]
   812   C1883725:replication [Qualitative Concept]
   741 E C0205173:Replicate [Functional Concept]
   741 E C0205341:Replicate [Functional Concept]

Phrase: "and"

Phrase: "amelioration of diabetes"

Phrase: "in pancreatectomized rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "by Reg protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(14"

Phrase: ")"

Phrase: ","

Phrase: "Therefore,"

Phrase: "we"

Phrase: "reasoned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0392360:Reason [Idea or Concept]

Phrase: "that linomide treatment of female NOD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with advanced disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "combined with this alternative approach"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205195:Combined [Qualitative Concept]
   760   C0449445:Approach [Spatial Concept]
   760   C1523987:Alternative [Conceptual Entity]
   726 E C0336789:Combine [Manufactured Object]

Phrase: "for -cell augmentation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "Reg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell expansion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007595:cell expansion [Cell Function]

Phrase: "might"

Phrase: "result in an improved salvage rate"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0085405:SALVAGE [Therapeutic or Preventive Procedure]
   753   C0184511:Improved [Qualitative Concept]
   753   C0332272:Improved [Qualitative Concept]
   753   C0442967:Salvage [Therapeutic or Preventive Procedure]
   753   C0871208:Rate [Activity]
   753   C1274040:Result [Functional Concept]
   753   C1521828:Rate [Quantitative Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1561611:Improved [Intellectual Product]
   753   C2825142:Result [Finding]

Phrase: "from clinical diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in this model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "of autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.22: We report herein our results with this approach.  

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "herein"

Phrase: "our results with this approach."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.23: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Animals Female NOD mice were purchased from Jackson Laboratory (Bar Harbor, ME). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animals Female NOD mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0085243:Mice, NOD [Mammal]
           NOD
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0751781:NOD [Disease or Syndrome]

Phrase: "were"

Phrase: "purchased from Jackson Laboratory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C0869011:purchased [Activity]
   770   C3244292:laboratory [Functional Concept]

Phrase: "(Bar Harbor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0475311:Harbor [Manufactured Object]

Phrase: "ME"

Phrase: ")."
Processing 00000000.tx.24: At 14 weeks of age, animals were phenotyped according to glucose tolerance and allocated to the different treatment groups. 

Phrase: "At 14 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "phenotyped according to glucose tolerance"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0178665:Glucose tolerance [Physiologic Function]
   760   C0013220:Tolerance [Finding]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0020963:Tolerance [Pathologic Function]
   760   C0220929:tolerance [Mental Process]
   760   C0231197:Tolerance [Physiologic Function]
   760   C0680240:according [Social Behavior]
   760   C1704410:Tolerance [Qualitative Concept]
   726   C0031437:Phenotype [Organism Attribute]
   726   C1285572:Phenotype [Laboratory Procedure]
   704 E C0680282:toleration [Social Behavior]

Phrase: "and"

Phrase: "allocated to the different treatment groups."
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705169:Treatment [Conceptual Entity]
   753   C1705242:Different [Qualitative Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
   753   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.25: Additional groups of animals were treated starting at 5 weeks of age. 

Phrase: "Additional groups of animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   802   C1642385:Animal group [Group]
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552839:groups [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "starting at 5 weeks of age."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
   719   C0439659:Start [Temporal Concept]
Processing 00000000.tx.26: The mice were maintained under specific pathogen-free conditions, fed ad libitum with autoclaved standard laboratory animal chow, and supplied with acidified water (pH 2.3). 

Phrase: "The mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "maintained under specific pathogen-free conditions,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0162470:Specific Pathogen Free [Organism]
   753   C0205369:Specific [Qualitative Concept]
   753   C0332296:free [Functional Concept]
   753   C0450254:Pathogen [Organism]
   753   C1314677:Maintained [Functional Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719 E C0024501:Maintain [Activity]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "fed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0342895:FED [Disease or Syndrome]
   966 E C0204695:Feed [Health Care Activity]
   966 E C2987508:Feed [Activity]

Phrase: "ad libitum with autoclaved standard laboratory animal chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879743:ad libitum [Qualitative Concept]

Phrase: "and"

Phrase: "supplied with acidified water"
Meta Candidates (Total=10; Excluded=5; Pruned=0; Remaining=5)
   802   C0043062:Water Supply [Quantitative Concept]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]
   770   C1999230:Supplied [Activity]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]

Phrase: "(pH 2.3"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0601906:PH 3 [Pharmacologic Substance]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.27: Treatment compounds Linomide. 

Phrase: "Treatment compounds Linomide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.28: Quinoline-3-carboxamide (linomide) was provided by Dr. 

Phrase: "Quinoline-3-carboxamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2716460:quinoline-3-carboxamide [Organic Chemical]

Phrase: "(linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "provided by Dr."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C1999230:Provided [Activity]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
Processing 00000000.tx.29: Terje Kalland, Division of Immunology, Pharmacia Upjohn (Lund, Sweden). 

Phrase: "Terje Kalland,"

Phrase: "Division of Immunology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: "Pharmacia Upjohn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0331920:Upjohn [Health Care Related Organization]
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "(Lund,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")."
Processing 00000000.tx.30: Freshly dissolved linomide was diluted to 0.5 mg/ml in normal drinking water (nonacidified tap water) and given daily for 10 weeks. 

Phrase: "Freshly dissolved linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "diluted to 0.5 mg/ml"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C2984062:mg/5 ml [Quantitative Concept]
   790   C0439294:mg ml [Quantitative Concept]
   790   C0444499:0/5 [Quantitative Concept]
   753   C0439269:mg% [Quantitative Concept]
   753   C0439526:/mL [Quantitative Concept]
   753   C1960952:mg % [Quantitative Concept]
   753   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "in normal drinking water"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0599638:Drinking Water [Substance]
           WATER
   827   C0001948:drinking [Individual Behavior]
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0684271:Drinking [Organism Function]
   827   C1550678:Water [Inorganic Chemical]
   793 E C0452428:Drink [Food]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: "(nonacidified tap water"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C2919405:Tap water [Inorganic Chemical,Pharmacologic Substance]
   827   C0034115:Tap [Health Care Activity]
   827   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   827   C0599638:WATER [Substance]
   827   C1550678:Water [Inorganic Chemical]
   755 E C0443350:Watery [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "given daily for 10 weeks."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332173:Daily [Temporal Concept]
Processing 00000000.tx.31: Reg peptide. 

Phrase: "Reg peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.32: The human reg complementary DNA encompassing the coding sequence was introduced into a Pichia pastoris expression vector for production of recombinant human Reg (rhReg) protein (15). 

Phrase: "The human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "reg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0334213:regenerating [Functional Concept]

Phrase: "complementary DNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "encompassing"

Phrase: "the coding sequence"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0079941:Coding Sequence [Gene or Genome]
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0009219:Coding [Occupational Activity]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   827 E C0805701:Code [Intellectual Product]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]

Phrase: "was"

Phrase: "introduced into a Pichia pastoris expression vector"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0599566:expression vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0031874:Pichia [Fungus]
   748   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0442335:Vector [Spatial Concept]
   748   C1705099:Vector [Idea or Concept]
   714   C1292748:introduce [Functional Concept]

Phrase: "for production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of recombinant human Reg (rhReg) protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0208940:REG protein, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   902   C0034861:Recombinant protein [Amino Acid, Peptide, or Protein]
   875   C1142652:human protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.33: rhReg containing yeast supernatant was concentrated by precipitation with a 60% saturated solution of ammonium sulfate. 

Phrase: "rhReg containing yeast supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "concentrated by precipitation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0032931:Precipitation [Natural Phenomenon or Process]
   790   C0032932:Precipitation [Molecular Function]
   790   C1642401:% precipitation [Quantitative Concept]
   790   C1880165:Concentrated [Biomedical or Dental Material]
   790   C2584299:Precipitation [Natural Phenomenon or Process]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]

Phrase: "with a 60% saturated solution"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0037633:Solution [Substance]
   827   C0522534:Saturated [Phenomenon or Process]
   827   C0525069:Solution [Biomedical or Dental Material]
   827   C1705188:SATURATED [Quantitative Concept]

Phrase: "of ammonium sulfate."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0002620:Ammonium Sulfate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0002611:Ammonium [Inorganic Chemical]
   861   C0038720:Sulfate [Inorganic Chemical]
   861   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   861   C3536965:SULFATE [Element, Ion, or Isotope]
Processing 00000000.tx.34: The precipitate was dissolved and then further concentrated and desalted using an Intersep apparatus (Intersep filtration systems, Berkshire, UK) with a 10-kDa cut-off membrane. 

Phrase: "The precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "was"

Phrase: "dissolved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549535:Dissolve [Functional Concept]

Phrase: "and"

Phrase: "then further"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1517331:Further [Spatial Concept]
   861   C1883708:Then [Temporal Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "desalted"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Intersep apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243111:apparatus [Manufactured Object]
   861   C1947951:Apparatus [Anatomical Structure]

Phrase: "(Intersep filtration systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]

Phrase: "Berkshire,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0454841:Berkshire [Geographic Area]

Phrase: "UK"

Phrase: ")"

Phrase: "with a 10-kDa cut-off membrane."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0025255:Membrane [Tissue]
   799   C0596901:Membrane [Cell Component]
   799   C1706182:Membrane [Manufactured Object]
   727 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.35: A dominant component of the protein concentrate migrates on 15% SDS-PAGE at the same position as the rhReg in unprocessed yeast medium and after ion exchange chromatography, and showed a band at 16.5 kDa that was detected by a monoclonal antihuman Reg antibody on Western blot (Fig. 1). 

Phrase: "A dominant component of the protein concentrate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1179435:Component of protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Protein Component
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]

Phrase: "migrates on 15% SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C0232902:migrate [Functional Concept]
   760   C1704732:Page [Intellectual Product]

Phrase: "at the same position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "as the rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "in unprocessed yeast medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "and after ion exchange chromatography,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0008564:Chromatography, Ion Exchange [Laboratory Procedure]
   862   C0687342:ION-EXCHANGE CHROMATOGRAPHY [Medical Device]
   806   C0022013:Ion Exchange [Molecular Function]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0022023:Ion [Element, Ion, or Isotope]
   760   C0678640:exchange [Social Behavior]
   760   C1515981:And [Idea or Concept]
   760   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a band at 16.5 kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0230715:A band [Cell Component]
   753   C0175723:Band [Medical Device]
   753   C0439645:Band [Spatial Concept]
   753   C1521913:band [Cell Component]

Phrase: "that"

Phrase: "was"

Phrase: "detected by a monoclonal antihuman Reg antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0442726:Detected [Finding]
   748   C0746619:monoclonal [Finding]
   748   C1419333:REG [Gene or Genome]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1705631:REG [Gene or Genome]

Phrase: "on Western blot"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0949466:Western Blot [Laboratory Procedure]
   861   C1705493:Western [Spatial Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.36: Before injection, the partially purified lyophylized protein was reconstituted at a concentration of 1 mg/ml in 50 mM acetic acid. 

Phrase: "Before injection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021485:injection [Therapeutic or Preventive Procedure]
  1000   C1272883:Injection [Biomedical or Dental Material]
  1000   C1533685:Injection [Therapeutic or Preventive Procedure]
  1000   C1828121:Injection [Functional Concept]

Phrase: "the partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "lyophylized protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "reconstituted at a concentration of 1 mg/ml"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0439294:mg ml [Quantitative Concept]
   744   C0086045:Concentration [Mental Process]
   744   C0439269:mg% [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1960952:mg % [Quantitative Concept]
   744   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "in 50 mM acetic acid."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0000985:Acetic acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   756 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.37: For control experiments, supernatant from non-Reg-expressing yeast was processed according to the same protocol. 

Phrase: "For control experiments,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0009932:control experiments [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0681814:Experiments [Research Activity]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "supernatant from non-Reg-expressing yeast"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "processed according to the same protocol."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0442711:Protocol [Intellectual Product]
   753   C0445247:Same [Qualitative Concept]
   753   C0680240:according [Social Behavior]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522240:Processed [Phenomenon or Process]
   753   C1522729:Protocol [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]
   719 E C1184743:Process [Body Part, Organ, or Organ Component]
Processing 00000000.tx.38: View larger version (75K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(75K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.39: Validation of rhReg in the semipurified yeast medium preparation by SDS-PAGE. 

Phrase: "Validation of rhReg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1519941:Validation [Research Activity]

Phrase: "in the semipurified yeast medium preparation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]

Phrase: "by SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]
Processing 00000000.tx.40: Lane A, Coomassie staining shows dominant bands migrating at 16.5 kDa, not seen in control medium preparation (not shown); 

Phrase: "Lane A,"

Phrase: "Coomassie staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "dominant bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0175723:Bands [Medical Device]
   827 E C0439645:Band [Spatial Concept]
   827 E C1521913:band [Cell Component]

Phrase: "migrating at 16.5 kDa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0232902:migrating [Functional Concept]
   760   C1532717:kDa [Quantitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "seen in control medium preparation"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   760   C0009458:Medium [Intellectual Product]
   760   C0205397:Seen [Qualitative Concept]
   760   C0243148:control [Qualitative Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C0455052:Preparation [Health Care Activity]
   760   C1521827:Preparation [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1705217:Medium [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3244283:medium [Intellectual Product]
   760   C3274648:Control [Qualitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.41: lane B, Western immunoblotting of the same medium analyzed under the same SDS-PAGE conditions with a monoclonal antihuman Reg I antibody; 

Phrase: "lane B,"

Phrase: "Western immunoblotting of the same medium"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   773 E C0949466:Western Immunoblot [Laboratory Procedure]
   753   C0020985:Immunoblotting [Laboratory Procedure]
   753   C1705493:Western [Spatial Concept]

Phrase: "analyzed under the same SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   753   C0445247:Same [Qualitative Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1704732:Page [Intellectual Product]

Phrase: "conditions with a monoclonal antihuman Reg I antibody"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0221138:I not otherwise specified Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           I NOS
   770   C0370188:i Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0012634:condition [Disease or Syndrome]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0021966:I- [Inorganic Chemical]
   744   C0348080:Condition [Qualitative Concept]
   744   C0746619:monoclonal [Finding]
   744   C1419333:REG [Gene or Genome]
   744   C1705253:Condition [Conceptual Entity]
   744   C1705631:REG [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.42: lane C, immunoblot of a pancreatic protein extract obtained from a diabetic female NOD mouse with the same antibody.  

Phrase: "lane C,"

Phrase: "immunoblot of a pancreatic protein extract"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "obtained from a diabetic female NOD mouse"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   778   C0085243:Mouse, NOD [Mammal]
           NOD
   748   C0015780:Female [Finding]
   748   C0025914:Mouse [Mammal]
   748   C0025929:mouse [Mammal]
   748   C0026809:Mouse [Mammal]
   748   C0043210:female [Population Group]
   748   C0086287:female [Population Group]
   748   C0241863:DIABETIC [Finding]
   748   C0751781:NOD [Disease or Syndrome]
   748   C1301820:Obtained [Functional Concept]
   748   C1705497:Female [Qualitative Concept]
   748   C1705498:Female [Qualitative Concept]
   714 E C1706701:Obtain [Activity]

Phrase: "with the same antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.43: Methods Intraperitoneal glucose tolerance test (IPGTT). 

Phrase: "Methods Intraperitoneal glucose tolerance test (IPGTT)."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   897   C0871511:methods test [Intellectual Product]
   884   C0017741:Glucose tolerance test [Diagnostic Procedure]
   853   C0337438:glucose test [Laboratory Procedure]
   853   C0595310:GLUCOSE TEST [Medical Device]
   840   C0178665:Glucose tolerance [Physiologic Function]
   840   C0201777:Tolerance test [Laboratory Procedure]
   804   C0013220:Tolerance [Finding]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0020963:Tolerance [Pathologic Function]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0220929:tolerance [Mental Process]
   804   C0231197:Tolerance [Physiologic Function]
   804   C0392366:test [Intellectual Product]
   804   C1704410:Tolerance [Qualitative Concept]
   748 E C0680282:toleration [Social Behavior]
   733 E C0231198:Tolerant [Functional Concept]
Processing 00000000.tx.44: The onset of impaired glucose tolerance (IGT) was detected by IPGTT performed on nonfasted animals. 

Phrase: "The onset of impaired glucose tolerance (IGT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "detected by IPGTT"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   833   C0017741:Glucose tolerance test [Diagnostic Procedure]
   790   C0178665:Glucose tolerance [Physiologic Function]
   790   C0201777:Tolerance test [Laboratory Procedure]
   783   C0337438:glucose test [Laboratory Procedure]
   783   C0595310:GLUCOSE TEST [Medical Device]
   753   C0013220:Tolerance [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0020963:Tolerance [Pathologic Function]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0220929:tolerance [Mental Process]
   753   C0231197:Tolerance [Physiologic Function]
   753   C0392366:test [Intellectual Product]
   753   C0442120:Intraperitoneal [Spatial Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1704410:Tolerance [Qualitative Concept]

Phrase: "performed on nonfasted animals."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.45: Blood was drawn from the paraorbital plexus 0 and 60 min after the ip injection of glucose (1 g/kg BW). 

Phrase: "Blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "drawn from the paraorbital plexus 0"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1184808:Plexus [Body Part, Organ, or Organ Component]
   719   C0013113:Draw [Intellectual Product]

Phrase: "and"

Phrase: "60 min after the ip injection of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0702093:/min [Temporal Concept]

Phrase: "(1 g/kg BW"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005910:BW [Organism Attribute]
   812   C0006041:BW [Geographic Area]
   812   C2986891:BW [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.46: Normal glucose tolerance (NGT) was defined as a time zero plasma glucose level of less than 8 mmol/liter or a 1 h post-ip glucose administration plasma glucose level of less than 8.9 mmol/L. 

Phrase: "Normal glucose tolerance (NGT)"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "was"

Phrase: "defined as a time zero plasma glucose level of less"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   782   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
   760   C0202042:Plasma glucose [Laboratory Procedure]
   760   C0337438:glucose level [Laboratory Procedure]
   760   C0428548:Glucose level [Laboratory or Test Result]
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0032105:Plasma [Body Substance]
   739   C0040223:Time [Temporal Concept]
   739   C0441889:Level [Qualitative Concept]
   739   C0456079:Level [Classification]
   739   C0919414:Zero [Quantitative Concept]
   739   C1547707:Level [Geographic Area]
   739   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   739   C1704788:Defined [Conceptual Entity]
   739   C2946261:Level [Pharmacologic Substance]
   739   C3539106:Defined [Intellectual Product]
   739   C3541383:Time [Temporal Concept]

Phrase: "than 8 mmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0475211:liter [Quantitative Concept]

Phrase: "or"

Phrase: "a 1 h post-ip glucose administration plasma glucose level of less"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   770   C0455280:plasma glucose level [Laboratory or Test Result]
           plasma glucose
           glucose plasma
   753   C0202042:Plasma glucose [Laboratory Procedure]
   751   C0337438:glucose level [Laboratory Procedure]
   751   C0428548:Glucose level [Laboratory or Test Result]
   751   C0456947:Level 1 [Intellectual Product]
   736   C0032105:Plasma [Body Substance]
   736   C0441889:Level [Qualitative Concept]
   736   C0456079:Level [Classification]
   736   C1547707:Level [Geographic Area]
   736   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   736   C2946261:Level [Pharmacologic Substance]

Phrase: "than 8.9 mmol/L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532563:mmol/L [Quantitative Concept]
Processing 00000000.tx.47: Animals with higher glucose concentrations were assigned to the IGT group. 

Phrase: "Animals with higher glucose concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0684068:higher animals [Animal]
   760   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "assigned to the IGT group."
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   814   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   778   C0178665:Glucose tolerance [Physiologic Function]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0220929:tolerance [Mental Process]
   748   C0221099:Impaired [Functional Concept]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0441833:Group [Idea or Concept]
   748   C0684336:Impaired [Pathologic Function]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1516050:Assigned [Functional Concept]
   748   C1552516:Group [Health Care Related Organization]
   748   C1552601:assigned [Intellectual Product]
   748   C1704410:Tolerance [Qualitative Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
Processing 00000000.tx.48: Blood glucose levels were determined with a Glucometer Elite apparatus (Bayer Diagnostics, Elkart, IN). 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "determined with a Glucometer Elite apparatus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243111:apparatus [Manufactured Object]
   753   C0472226:Glucometer [Medical Device]
   753   C1947951:Apparatus [Anatomical Structure]

Phrase: "(Bayer Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Elkart,"

Phrase: "IN"

Phrase: ")."
Processing 00000000.tx.49: Linomide and Reg peptide administration to female NOD mice with advanced disease. 

Phrase: "Linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "Reg peptide administration to female NOD mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0001554:Administration [Occupational Activity]
   748   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "with advanced disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.50: Fourteen-week-old animals with both NGT and IGT were assigned to four treatment groups: a) control group, rhReg vehicle or processed non-rhReg-expressing yeast medium, ip; 

Phrase: "Fourteen-week-old animals with both NGT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "IGT"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "were"

Phrase: "assigned to four treatment groups"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0205450:Four [Quantitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1516050:Assigned [Functional Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1552516:Group [Health Care Related Organization]
   760   C1552601:assigned [Intellectual Product]
   760   C1552839:groups [Idea or Concept]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C3538994:TREATMENT [Research Activity]

Phrase: ":"

Phrase: "a) control group,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   913   C0441835:a group [Classification]
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "rhReg vehicle"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0042444:Vehicle [Biomedical or Dental Material]
   812   C0348005:Vehicle [Manufactured Object]
   741 E C0445373:Vehicular [Functional Concept]

Phrase: "or"

Phrase: "processed non-rhReg-expressing yeast medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0009458:Medium [Intellectual Product]
   793   C0439536:Medium [Quantitative Concept]
   793   C1705217:Medium [Substance]
   793   C3244283:medium [Intellectual Product]

Phrase: "ip"

Phrase: ";"
Processing 00000000.tx.51: b) rhReg (1 mg/kgday, ip, daily; six times a week; a dose shown to be effective in the pancreatectomized rat model) (14); 

Phrase: "b) rhReg (1 mg/kgday,"

Phrase: "ip,"

Phrase: "daily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332173:Daily [Temporal Concept]

Phrase: "; six times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "a week"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332174:/week [Temporal Concept]
  1000   C0439230:week [Temporal Concept]

Phrase: ";"

Phrase: "a dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "effective in the pancreatectomized rat model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280519:effective [Qualitative Concept]
   753   C1704419:Effective [Qualitative Concept]

Phrase: ")"

Phrase: "(14"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.52: c) linomide (0.5 mg/ml in drinking water) (12); 

Phrase: "c) linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.5 mg/ml in drinking water"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C2984062:mg/5 ml [Quantitative Concept]
   778   C0439294:mg ml [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "(12"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.53: and d) linomide (0.5 mg/ml, orally) and rhReg (1 mg/kgday, ip, daily). 

Phrase: "and"

Phrase: "d)"

Phrase: "linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.5 mg/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "orally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442027:Orally [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "rhReg (1 mg/kgday,"

Phrase: "ip,"

Phrase: "daily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332173:Daily [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.54: The level of urinary glucose (Labstix, Bayer Diagnostics, Hampshire, UK) was followed on a biweekly basis. 

Phrase: "The level of urinary glucose"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0337438:glucose level [Laboratory Procedure]
   797   C0428548:Glucose level [Laboratory or Test Result]
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "(Labstix,"

Phrase: "Bayer Diagnostics,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011900:Diagnostic [Finding]
   827   C0348026:Diagnostic [Functional Concept]

Phrase: "Hampshire,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0324247:Hampshire [Mammal]
  1000   C0454857:Hampshire [Geographic Area]

Phrase: "UK"

Phrase: ")"

Phrase: "was"

Phrase: "followed on a biweekly basis."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0332283:followed [Temporal Concept]
   760   C0585332:Biweekly [Temporal Concept]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.55: The onset of diabetes was determined after the appearance of glucosuria on at least two consecutive determinations. 

Phrase: "The onset of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332162:Onset [Qualitative Concept]

Phrase: "was"

Phrase: "determined after the appearance of glucosuria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0017979:Glucosuria [Finding]
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "on"

Phrase: "at least two consecutive determinations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.56: After 10 weeks of treatment, in view of the increased nondiabetes-related mortality noted in group d animals (see Results), the experiments were terminated. 

Phrase: "After 10 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "in view of the increased nondiabetes-related mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0026565:Mortality [Quantitative Concept]
   812   C0026566:mortality [Quantitative Concept]

Phrase: "noted in group d animals"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0441838:Group D [Classification]
   781   C1642385:Animal group [Group]
   760   C0003062:Animals [Animal]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: ")"

Phrase: ","

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "terminated."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C1553404:terminated [Idea or Concept]
  1000   C2348570:Terminated [Functional Concept]
   928 E C0011065:Expired [Organism Function]
   928 E C0231800:Expired [Organ or Tissue Function]
   928 E C1704631:Expire [Idea or Concept]
   907 E C0184532:dying [Organism Function]
   907 E C1546956:Died [Finding]
Processing 00000000.tx.57: In the surviving animals, an additional IPGTT was performed, and the following day they were killed for histopathological evaluation and determination of pancreatic immunoreactive insulin (IRI) content. 

Phrase: "In the surviving animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "an additional IPGTT"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   884   C0017741:Glucose tolerance test [Diagnostic Procedure]
   853   C0337438:glucose test [Laboratory Procedure]
   853   C0595310:GLUCOSE TEST [Medical Device]
   840   C0178665:Glucose tolerance [Physiologic Function]
   840   C0201777:Tolerance test [Laboratory Procedure]
   804   C0013220:Tolerance [Finding]
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   804   C0020963:Tolerance [Pathologic Function]
   804   C0022885:Test [Laboratory Procedure]
   804   C0039593:Test [Functional Concept]
   804   C0220929:tolerance [Mental Process]
   804   C0231197:Tolerance [Physiologic Function]
   804   C0392366:test [Intellectual Product]
   804   C1704410:Tolerance [Qualitative Concept]
   748 E C0680282:toleration [Social Behavior]
   733 E C0231198:Tolerant [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: ","

Phrase: "and"

Phrase: "the following day"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "they"

Phrase: "were"

Phrase: "killed for histopathological evaluation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0162388:killed [Social Behavior]
   770   C0220825:Evaluation [Functional Concept]
   770   C1261322:Evaluation [Health Care Activity]
   737 E C0681205:Kill [Idea or Concept]
   737 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "determination of pancreatic immunoreactive insulin (IRI) content."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.58: rhReg administration to prediabetic female NOD. 

Phrase: "rhReg administration to prediabetic female NOD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0001554:Administration [Occupational Activity]
   744   C1533734:Administration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.59: Five-week-old animals were treated as described for group b above from 512 weeks of age. 

Phrase: "Five-week-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "as"

Phrase: "described for group b"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1552738:described [Idea or Concept]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]

Phrase: "above from 512 weeks of age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1282910:Above [Spatial Concept]
   753   C1552828:above [Idea or Concept]
Processing 00000000.tx.60: Therapy was then discontinued and animals were followed to 40 weeks of age, at which time determinations were made as detailed above for mice with advanced disease. 

Phrase: "Therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "discontinued"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1444662:Discontinued [Finding]
   966 E C1706472:Discontinue [Intellectual Product]

Phrase: "and"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "followed to 40 weeks of age,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0001779:Age [Organism Attribute]
   753   C0332283:followed [Temporal Concept]
   753   C0439230:weeks [Temporal Concept]
   753   C0439509:/40 [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "at which time determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0680730:determinations [Governmental or Regulatory Activity]
   827 E C1148554:determination [Laboratory Procedure]

Phrase: "were"

Phrase: "made as detailed above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1522508:Detailed [Qualitative Concept]
   737   C1881534:Make [Functional Concept]

Phrase: "for mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "with advanced disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.61: Untreated female mice served as controls. 

Phrase: "Untreated female mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "served as controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.62: Control group animals and a group of rhReg-treated animals were killed and examined at 21 weeks of age. 

Phrase: "Control group animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   896   C1511501:Control Animal [Animal]
   827   C0003062:Animals [Animal]
   734   C0009932:Control Group [Group]

Phrase: "and"

Phrase: "a group of rhReg-treated animals"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0441835:a group [Classification]
   767   C0683626:human group [Population Group]
   750   C1642385:Animal group [Group]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: "and"

Phrase: "examined at 21 weeks of age."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0332128:Examined [Finding]
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
Processing 00000000.tx.63: Pancreatic islet histology. 

Phrase: "Pancreatic islet histology."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0019638:Histology [Biomedical Occupation or Discipline]
   827   C0205462:histology [Functional Concept]
   827   C0344441:Histology [Laboratory Procedure]
   734   C0022131:Pancreatic islet [Body Part, Organ, or Organ Component]
Processing 00000000.tx.64: Pancreatic tissue was removed, fixed in 10% formalin in 0.9% saline, and embedded in wax. 

Phrase: "Pancreatic tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "fixed in 10% formalin"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   833   C1561470:10% Formalin [Intellectual Product]
   770   C0231441:Fixed [Finding]
   770   C0443218:Fixed [Qualitative Concept]
   770   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   770   C2827483:Fixed [Body Substance]

Phrase: "in 0.9% saline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036082:Saline [Substance]

Phrase: "and"

Phrase: "embedded in wax."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043076:wax [Biologically Active Substance,Biomedical or Dental Material,Lipid]
   790   C0740486:Wax [Body Substance]
   790   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.65: Two sets of five serial 5-m sections were cut for immunolabeling at a cutting interval of 150 m. 

Phrase: "Two sets of five serial 5-m sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0036849:Set [Mental Process]
   744   C1442518:Set [Functional Concept]
   744   C1705195:Set [Conceptual Entity]

Phrase: "were"

Phrase: "cut for immunolabeling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0000925:Cut [Injury or Poisoning]
   790   C1883724:CUT [Phenomenon or Process]

Phrase: "at a cutting interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: "of 150 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.66: Sections were immunolabeled for insulin (guinea pig antiinsulin dilution, 1:1000; 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "immunolabeled for insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(guinea pig antiinsulin dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079240:Dilution [Laboratory Procedure]
   812   C1948037:Dilution [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.67: ICN, Thame, UK) and glucagon (rabbit antipancreatic glucagon dilution, 1:2000) and detected with peroxidase-conjugated antiguinea pig (Dako, High Wycombe, UK) or peroxidase-conjugated antirabbit antisera (dilution, 1:50; 

Phrase: "ICN,"

Phrase: "Thame,"

Phrase: "UK"

Phrase: ")"

Phrase: "and"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(rabbit antipancreatic glucagon dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0079240:Dilution [Laboratory Procedure]
   812   C1948037:Dilution [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "detected with peroxidase-conjugated antiguinea pig"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0442726:Detected [Finding]
   753   C0522529:Conjugated [Spatial Concept]
   753   C1135183:Pig [Mammal]
   753   C1136016:PIG [Mammal]
   753   C1265533:Pig [Mammal]
   753   C1270360:Pig [Mammal]
   753   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "(Dako,"

Phrase: "High Wycombe,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "UK"

Phrase: ")"

Phrase: "or"

Phrase: "peroxidase-conjugated antirabbit antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "50"

Phrase: ";"
Processing 00000000.tx.68: Dako). 

Phrase: "Dako"

Phrase: ")."
Processing 00000000.tx.69: Morphometry. 

Phrase: "Morphometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0200760:Morphometry [Laboratory Procedure]
Processing 00000000.tx.70: Areas of pancreatic islets (islet area), immunolabeled -cells (-cell area), and lymphocytic infiltrate into islets (area of infiltrate) were measured by camera lucida at a magnification of x600. 

Phrase: "Areas of pancreatic islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0205146:areas [Spatial Concept]
   737 E C0017446:Area [Geographic Area]

Phrase: "(islet area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "immunolabeled -"

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(-cell area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lymphocytic infiltrate into islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0333386:Lymphocytic infiltrate [Pathologic Function]
   770   C0332448:Infiltrate [Pathologic Function]
   770   C1546677:Infiltrate [Intellectual Product]
   770   C1549537:Infiltrate [Functional Concept]

Phrase: "(area of infiltrate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017446:Area [Geographic Area]
   790   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "measured by camera lucida"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0179533:Camera [Medical Device]
   770   C0444706:Measured [Qualitative Concept]
   770   C1654607:Camera [Eukaryote]
   770   C1706254:CAMERA [Medical Device]
   770   C2630991:Lucida [Eukaryote]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "at a magnification"

Phrase: "of x600."
Processing 00000000.tx.71: Morphometric data were analyzed by IBAS (Kontron, Munich, Germany) for statistical analysis. 

Phrase: "Morphometric data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "analyzed by IBAS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0936012:Analyzed [Research Activity]

Phrase: "(Kontron,"

Phrase: "Munich,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "for statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.72: Data were collected from all islets in both sets of sections (n = 220 islets). 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected from all islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "in both"

Phrase: "sets of sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756   C0205155:Section [Spatial Concept]
   756   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   756   C1522472:Section [Substance]
   756   C1552923:Section [Quantitative Concept]
   756   C1705191:Section [Physical Object]

Phrase: "(n = 220 islets"

Phrase: ")."
Processing 00000000.tx.73: In the absence of insulin immunoreactivity, data were derived from adjacent sections labeled for glucagon. 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of insulin immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "derived from adjacent sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0205117:Adjacent [Spatial Concept]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C0205155:Section [Spatial Concept]
   737   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   737   C1522472:Section [Substance]
   737   C1552923:Section [Quantitative Concept]
   737   C1705191:Section [Physical Object]

Phrase: "labeled for glucagon."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.74: Clusters of more than three cells were considered to be an islet, and only infiltration associated with islets was included. 

Phrase: "Clusters of more"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1555715:Cluster [Idea or Concept]
   756   C1704332:Cluster [Quantitative Concept]

Phrase: "than three cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an islet,"

Phrase: "and"

Phrase: "only infiltration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332448:Infiltration [Pathologic Function]
   861   C0702249:Infiltration [Therapeutic or Preventive Procedure]
   861   C1523986:Infiltration [Functional Concept]

Phrase: "associated with islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "included."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]
Processing 00000000.tx.75: Pancreatic IRI concentration. 

Phrase: "Pancreatic IRI concentration."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.76: Fragments (7050 mg) of pancreatic tissue were weighed, sonicated in 1 ml ice-cold 1 M acetic acid, and gently rocked at 4 C for 16 h. 

Phrase: "Fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]

Phrase: "(7050 mg) of pancreatic tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439269:mg% [Quantitative Concept]
   760   C1960952:mg % [Quantitative Concept]
   760   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "were"

Phrase: "weighed"

Phrase: ","

Phrase: "sonicated in 1 ml ice-cold 1 M acetic acid,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   760   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   760   C0000985:Acetic acid [Organic Chemical]
   760   C0456963:Ice cold [Qualitative Concept]
   739   C0001128:Acid [Chemical]
   739   C0009264:Cold [Natural Phenomenon or Process]
   739   C0009443:Cold [Disease or Syndrome]
   739   C0020746:Ice [Inorganic Chemical]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0234192:Cold [Physiologic Function]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439526:/mL [Quantitative Concept]
   739   C0441923:M+ [Intellectual Product]
   739   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "rocked at 4 C"

Phrase: "for 16 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.77: The particulate fraction was then sedimented by centrifugation in a microfuge at maximal speed for 5 min. 

Phrase: "The particulate fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "sedimented by centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C1550099:Sediment [Body Substance]

Phrase: "in a microfuge"

Phrase: "at maximal speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678536:Speed [Quantitative Concept]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.78: The supernatants were removed, and aliquots were dried down in a Speed-Vac apparatus (Savant Instruments, Hicksville, NY), reconstituted in 1 ml RIA buffer (PBS containing 0.1% RIA grade BSA), and assayed for IRI using a rat insulin RIA as previously described (16). 

Phrase: "The supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "dried down"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C1512080:Dried [Qualitative Concept]
   833   C2827485:Dried [Body Substance]
   799 E C0011682:Dry [Natural Phenomenon or Process]
   799 E C0205222:Dry [Qualitative Concept]

Phrase: "in a Speed-Vac apparatus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0243111:apparatus [Manufactured Object]
   827   C1947951:Apparatus [Anatomical Structure]

Phrase: "(Savant Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Hicksville,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "reconstituted in 1 ml RIA buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0034580:RIA [Laboratory Procedure]
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% RIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034580:RIA [Laboratory Procedure]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "BSA"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "assayed for IRI"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737   C0005507:Assay [Laboratory Procedure]
   737   C0243073:assay [Qualitative Concept]
   737   C1510438:Assay [Laboratory Procedure]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rat insulin RIA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034580:RIA [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.79: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.80: Statistical significance was determined for group comparisons with Mann-Whitneys test and for survival curves by the log rank test. 

Phrase: "Statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "was"

Phrase: "determined for group comparisons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C1707455:Comparison [Activity]

Phrase: "with Mann-Whitneys test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   988   C1708930:Mann-Whitney Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "and for survival curves"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0038952:Survival [Activity]
   770   C0220921:survival [Functional Concept]
   770   C1515981:And [Idea or Concept]
   737   C0205134:Curve [Spatial Concept]

Phrase: "by the log rank test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C0699794:Rank [Intellectual Product]
   827   C1708728:Log [Intellectual Product]
   827   C2986775:log [Occupational Activity]
Processing 00000000.tx.81: Survival curves in which reversal of the incidence of glucosuria was observed were compared by Fishers exact test at the end of the experiment.  

Phrase: "Survival curves in which reversal of the incidence of glucosuria"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0038952:Survival [Activity]
   739   C0220921:survival [Functional Concept]
   706   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "compared by Fishers exact test"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   851   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0392366:test [Intellectual Product]
   760   C1707455:Compared [Activity]
   760   C2828393:Exact [Qualitative Concept]
   726   C0325045:Fisher [Mammal]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.82: Results Top Abstract Introduction Materials and Methods Results Discussion References  Occurrence of diabetes The appearance of diabetes in 14-week-old animals compared to that in untreated controls is shown in Fig. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Occurrence of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243132:occurrence [Functional Concept]
   790   C1554210:occurrence [Idea or Concept]
   790   C2745955:Occurrence [Temporal Concept]

Phrase: "The appearance of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233426:Appearance [Organism Attribute]
   770   C0700364:Appearance [Qualitative Concept]

Phrase: "in 14-week-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "compared to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in untreated controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0332155:untreated [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "is"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.83: 2, with NGT animals shown in A and IGT animals in B. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "with NGT animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "shown in A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "IGT animals in B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0003062:Animals [Animal]
Processing 00000000.tx.84: The incidence of diabetes in control animals (group a) was 60% and 86% for the NGT and IGT groups, respectively. 

Phrase: "The incidence of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "in control animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C1511501:Control Animal [Animal]
   861   C0003062:Animals [Animal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(group a"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441835:Group A [Classification]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: "was"

Phrase: "60%"

Phrase: "and"

Phrase: "86% for the NGT"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0178665:Glucose tolerance [Physiologic Function]
   790   C0860800:normal glucose [Finding]
   753   C0013220:Tolerance [Finding]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0020963:Tolerance [Pathologic Function]
   753   C0205307:Normal [Qualitative Concept]
   753   C0220929:tolerance [Mental Process]
   753   C0231197:Tolerance [Physiologic Function]
   753   C0439166:% normal [Quantitative Concept]
   753   C1704410:Tolerance [Qualitative Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "IGT groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1552839:groups [Idea or Concept]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]
   756   C0271650:Impaired glucose tolerance [Disease or Syndrome]

Phrase: "respectively."
Processing 00000000.tx.85: In groups c and d, treated with linomide or with linomide plus rhReg injections, no NGT animals developed diabetes over the 10-week period of the study; 

Phrase: "In groups c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441837:Group C [Classification]

Phrase: "and"

Phrase: "d,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "treated with linomide"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "or with linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "plus rhReg injections,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0021485:injections [Therapeutic or Preventive Procedure]
   812   C1533685:INJECTIONS [Therapeutic or Preventive Procedure]
   812   C1828121:Injections [Functional Concept]
   779 E C1272883:Injection [Biomedical or Dental Material]

Phrase: "no NGT animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "developed"

Phrase: "diabetes over the 10-week period of the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.86: in NGT animals receiving rhReg treatment alone (group b), partial protection was observed: 20% developed diabetes compared with 60% in the control group (P < 0.03). 

Phrase: "in NGT animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "rhReg treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(group b"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "partial protection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1545588:Protection [Finding]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ":"

Phrase: "20% developed diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "compared with 60%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(P < 0.03"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.87: In the IGT animals (Fig. 2B), mice in all groups rapidly developed diabetes, attaining an incidence of 3050% after 2 weeks of treatment. 

Phrase: "In the IGT animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003062:Animals [Animal]
   756   C0271650:Impaired glucose tolerance [Disease or Syndrome]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "mice in all"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0025914:Mice [Mammal]
   790   C0025929:mice [Mammal]
   790   C0026809:Mice [Mammal]

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "rapidly developed diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "attaining"

Phrase: "an incidence of 3050%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "after 2 weeks"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442457:2 Weeks [Temporal Concept]
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.88: After this time, a reversal of glucosuria was observed in animals treated with combined rhReg and linomide (group d), with a diminution of the incidence to 13% after 10 weeks of treatment compared with 80% in the control group (P < 0.0001). 

Phrase: "After this time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "a reversal of glucosuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443290:Reversal [Functional Concept]

Phrase: "was"

Phrase: "observed in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C1441672:Observed [Functional Concept]

Phrase: "treated with combined rhReg"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0086418:Human [Human]
   753   C0205195:Combined [Qualitative Concept]
   753   C1419333:REG [Gene or Genome]
   753   C1514798:recombinant [Organism]
   753   C1522326:Treated [Functional Concept]
   753   C1705631:REG [Gene or Genome]
   719 E C0336789:Combine [Manufactured Object]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "(group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "d)"

Phrase: ","

Phrase: "with a diminution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332511:Diminution [Qualitative Concept]

Phrase: "of the incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "to 13%"

Phrase: "after 10 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "compared with 80%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(P < 0.0001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.89: This contrasted with the steady increase in the incidence of diabetes in the other groups treated with each agent alone (Fig. 2B). 

Phrase: "This"

Phrase: "contrasted with the steady increase"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0205361:Steady [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0449900:contrasted [Diagnostic Procedure]
   726 E C1979874:Contrast [Qualitative Concept]

Phrase: "in the incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0021149:Incidence [Quantitative Concept]
  1000   C0220856:incidence [Functional Concept]
   928 E C1551358:incident [Idea or Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in the"

Phrase: "other groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "treated with each agent"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0450442:Agent [Chemical Viewed Functionally]
   770   C1254351:Agent [Pharmacologic Substance]
   770   C1521826:Agent [Intellectual Product]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.90: With the exception of the combined rhReg and linomide group, all animals with frank diabetes remained diabetic and succumbed to the disease within 46 weeks after the onset of glucosuria (data not shown). 

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of the combined rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1419333:REG [Gene or Genome]
   812   C1705631:REG [Gene or Genome]

Phrase: "and"

Phrase: "linomide group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "all animals with frank diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0003062:Animals [Animal]

Phrase: "remained"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "succumbed to the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "within 46 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "after the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of glucosuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017979:Glucosuria [Finding]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.91: In view of the experiments which indicated a partial protective effect of the rhReg peptide alone in mice with less severe disease (group b, NGT) and the deleterious effects of combined therapy (group d; see below), we further investigated the impact of rhReg by treatment of prediabetic, 5-week-old animals with rhReg alone for a limited period (Fig. 3). 

Phrase: "In view of the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "which"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a partial protective effect of the rhReg peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "alone in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205171:Alone [Quantitative Concept]
   790   C0439044:alone [Finding]
   790   C0679994:alone [Group Attribute]

Phrase: "with less severe disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(group b,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "NGT"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the deleterious effects of combined therapy"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1518681:Therapy Effect [Finding]
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(group d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441838:Group D [Classification]

Phrase: ";"

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")"

Phrase: ","

Phrase: "we further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the impact of rhReg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1825598:IMPACT [Gene or Genome]

Phrase: "by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "of prediabetic, 5-week-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animals [Animal]

Phrase: "with rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "alone for a limited period"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205171:Alone [Quantitative Concept]
   760   C0439044:alone [Finding]
   760   C0679994:alone [Group Attribute]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.92: Over 80% of control mice developed diabetes by 21 weeks of age, whereas only 25% of the rhReg-treated mice developed the disease at 40 weeks of age (P < 0.0001). 

Phrase: "Over 80%"

Phrase: "of control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "developed"

Phrase: "diabetes by 21 weeks of age,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]

Phrase: "whereas"

Phrase: "only 25% of the rhReg-treated mice"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   742   C0025914:Mice [Mammal]
   742   C0025929:mice [Mammal]
   742   C0026809:Mice [Mammal]
   742   C0086418:Human [Human]
   742   C0205171:Only [Quantitative Concept]
   742   C0332293:treated [Therapeutic or Preventive Procedure]
   742   C1419333:REG [Gene or Genome]
   742   C1514798:recombinant [Organism]
   742   C1522326:Treated [Functional Concept]
   742   C1705631:REG [Gene or Genome]
   742   C1720467:Only [Intellectual Product]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "developed"

Phrase: "the disease at 40 weeks of age (P < 0.0001"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0012634:Disease [Disease or Syndrome]

Phrase: ")."
Processing 00000000.tx.93: View larger version (18K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.94: Cumulative incidence of diabetes in glucose-tolerant (A) and glucose-intolerant (B) 14-week-old female NOD control, rhReg-treated, linomide-treated, and rhReg- plus linomide-treated mice followed for 10 weeks. 

Phrase: "Cumulative incidence of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "in glucose-tolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231198:Tolerant [Functional Concept]

Phrase: "(A)"

Phrase: "and"

Phrase: "glucose-intolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231200:Intolerant [Functional Concept]

Phrase: "(B) 14-week-old female NOD control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0243148:control [Qualitative Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]

Phrase: "rhReg-treated, linomide-treated,"

Phrase: "and"

Phrase: "rhReg- plus linomide-treated mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "followed for 10 weeks."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0332283:followed [Temporal Concept]
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]
   737 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.95: The presence of diabetes was ascertained on the basis of at least two consecutive determinations of glucosuria greater than 11.1 mmol/liter (Labstix, Bayer Diagnostics UK). 

Phrase: "The presence of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "ascertained on the basis of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]

Phrase: "at least two consecutive determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0680730:determinations [Governmental or Regulatory Activity]
   779 E C1148554:determination [Laboratory Procedure]

Phrase: "of glucosuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017979:Glucosuria [Finding]

Phrase: "greater than 11.1 mmol/liter"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439093:Greater Than [Quantitative Concept]
   753   C0443228:greater [Quantitative Concept]
   753   C1704243:Greater [Quantitative Concept]
   719 E C0549177:Great [Quantitative Concept]

Phrase: "(Labstix,"

Phrase: "Bayer Diagnostics UK"

Phrase: ")."
Processing 00000000.tx.96: The number of animals in each treatment group ranged from 1416.  

Phrase: "The number of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in each treatment group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705169:Treatment [Conceptual Entity]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "ranged from 1416."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]
Processing 00000000.tx.97: View larger version (12K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.98: Cumulative incidence of diabetes in 5-week-old prediabetic female NOD mice treated with rhReg and control mice followed up to age 40 weeks (n = 11 in each group). 

Phrase: "Cumulative incidence of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021149:Incidence [Quantitative Concept]
   770   C0220856:incidence [Functional Concept]

Phrase: "in 5-week-old prediabetic female NOD mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   818   C0085243:Mice, NOD [Mammal]
           NOD
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]
   795   C0751781:NOD [Disease or Syndrome]

Phrase: "treated with rhReg"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0086418:Human [Human]
   760   C1419333:REG [Gene or Genome]
   760   C1514798:recombinant [Organism]
   760   C1522326:Treated [Functional Concept]
   760   C1705631:REG [Gene or Genome]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "control mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "followed up to age 40 weeks"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   773   C0589120:Follow-up [Finding]
   773   C1522577:follow-up [Health Care Activity]
   773   C1704685:FOLLOW-UP [Intellectual Product]
   773   C3274571:FOLLOW-UP [Health Care Activity]
   753   C0001779:Age [Organism Attribute]
   753   C0332283:followed [Temporal Concept]
   753   C0439230:weeks [Temporal Concept]
   753   C0439509:/40 [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "(n = 11 in each group"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   797   C0441848:Group N [Intellectual Product]
   760   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441833:Group [Idea or Concept]
   760   C0441922:N+ [Intellectual Product]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1553036:[n] [Quantitative Concept]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.99: The presence of diabetes was ascertained as described in Fig. 

Phrase: "The presence of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "ascertained"

Phrase: "as"

Phrase: "described in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   790   C1552738:described [Idea or Concept]
Processing 00000000.tx.100: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.101: The rectangle depicts the duration of treatment with rhReg as described in Materials and Methods. 

Phrase: "The rectangle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205142:Rectangle [Spatial Concept]

Phrase: "depicts"

Phrase: "the duration of treatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C0444921:Duration of treatment [Temporal Concept]
           duration treatment
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: "with rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.102: Surviving mice in the control group (n = 2) were not followed after 21 weeks of age.  

Phrase: "Surviving mice in the control group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025914:Mice [Mammal]
   753   C0025929:mice [Mammal]
   753   C0026809:Mice [Mammal]

Phrase: "(n = 2)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "followed after 21 weeks of age."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C0001779:Age [Organism Attribute]
   753   C0332283:followed [Temporal Concept]
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.103: Morbidity and mortality In mice with advanced disease at 24 weeks of age, deaths unrelated to diabetes were noted in group d animals (rhReg plus linomide; 5 of 17 and 7 of 16 in the glucose-tolerant and glucose-intolerant subgroups, respectively). 

Phrase: "Morbidity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026538:Morbidity [Quantitative Concept]
  1000   C0220880:morbidity [Intellectual Product]

Phrase: "and"

Phrase: "mortality In mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026565:Mortality [Quantitative Concept]
   790   C0026566:mortality [Quantitative Concept]

Phrase: "with advanced disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "at 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "deaths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:deaths [Organism Function]
  1000   C1306577:DEATHS [Finding]

Phrase: "unrelated to diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0445356:Unrelated [Finding]
   790   C1704623:Unrelated [Qualitative Concept]
   718 E C0680208:unrelatedness [Social Behavior]

Phrase: "were"

Phrase: "noted in group d animals"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   806   C0441838:Group D [Classification]
   781   C1642385:Animal group [Group]
   760   C0003062:Animals [Animal]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   726   C1316572:Note [Clinical Attribute]
   726   C1317574:Note [Intellectual Product]
   726   C1369612:Note [Clinical Attribute]

Phrase: "(rhReg plus linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "; 5 of 17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439084:>5 [Quantitative Concept]
   790   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "7 of 16"

Phrase: "in the glucose-tolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0231198:Tolerant [Functional Concept]

Phrase: "and"

Phrase: "glucose-intolerant subgroups,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1079230:subgroups [Virus]
   793 E C1515021:Subgroup [Classification]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.104: The cause of this unexpected mortality was presumably related to the marked peritoneal fibrosis observed in animals receiving both rhReg and linomide. 

Phrase: "The cause of this unexpected mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "was"

Phrase: "presumably"

Phrase: "related to the marked peritoneal fibrosis"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0521607:Peritoneal Fibrosis [Disease or Syndrome]
   753   C0016059:Fibrosis [Pathologic Function]
   753   C0031153:Peritoneal [Body Part, Organ, or Organ Component]
   753   C0439849:Related [Qualitative Concept]
   753   C0442034:peritoneal [Body Location or Region]
   753   C0445223:Related [Finding]
   753   C0522501:Marked [Qualitative Concept]
   753   C1706089:Marked [Qualitative Concept]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "observed in animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C1441672:Observed [Functional Concept]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "both rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "and"

Phrase: "linomide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.105: In groups c and d and in the prediabetic group treated with rhReg alone from 512 weeks, no adverse reactions or nondiabetes-related mortality were noted. 

Phrase: "In groups c"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441837:Group C [Classification]

Phrase: "and"

Phrase: "d"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and in the prediabetic group"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0362046:pre-diabetic [Disease or Syndrome]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1515981:And [Idea or Concept]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "treated with rhReg"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0086418:Human [Human]
   760   C1419333:REG [Gene or Genome]
   760   C1514798:recombinant [Organism]
   760   C1522326:Treated [Functional Concept]
   760   C1705631:REG [Gene or Genome]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "alone from 512 weeks,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205171:Alone [Quantitative Concept]
   770   C0439044:alone [Finding]
   770   C0679994:alone [Group Attribute]

Phrase: "no adverse reactions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0559546:Adverse reactions [Finding]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "or"

Phrase: "nondiabetes-related mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026565:Mortality [Quantitative Concept]
   827   C0026566:mortality [Quantitative Concept]

Phrase: "were"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.106: Blood glucose levels and IPGTTs in nondiabetic animals To obtain better assessment of metabolic control, blood glucose levels and, in some experiments, IPGTTs were determined at the end point of experiments in nondiabetic animals. 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: "IPGTTs in nondiabetic animals To"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "better assessment of metabolic control,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1261322:Assessment [Health Care Activity]
   760   C1516048:Assessment [Activity]

Phrase: "blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "and"

Phrase: ","

Phrase: "in some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "IPGTTs"

Phrase: "were"

Phrase: "determined at the end point of experiments"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C2349179:End Point [Qualitative Concept]
   778   C2826544:ENDPOINT [Quantitative Concept]
   748   C0444930:End [Spatial Concept]
   748   C0681814:Experiments [Research Activity]
   748   C1552961:Point [Quantitative Concept]
   748   C2347617:point [Quantitative Concept]
   748   C2746065:End [Temporal Concept]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "in nondiabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.107: Fourteen-week-old animal experiments. 

Phrase: "Fourteen-week-old animal experiments."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   840   C0205664:Animal Experiments [Research Activity]
   804   C0003062:Animal [Animal]
   804   C0681814:Experiments [Research Activity]
   771 E C1706386:Experiment [Conceptual Entity]
   721 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.108: In the animals assigned initially to the NGT group, the control group was glucose intolerant after 10 weeks of treatment. 

Phrase: "In the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "assigned"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516050:Assigned [Functional Concept]
  1000   C1552601:assigned [Intellectual Product]

Phrase: "initially to the NGT group,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   778   C0178665:Glucose tolerance [Physiologic Function]
   778   C0860800:normal glucose [Finding]
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0205265:Initially [Temporal Concept]
   748   C0205307:Normal [Qualitative Concept]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0439166:% normal [Quantitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1552516:Group [Health Care Related Organization]
   748   C1704410:Tolerance [Qualitative Concept]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C2347086:% Normal [Quantitative Concept]

Phrase: "the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "glucose intolerant after 10 weeks of treatment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0231200:Intolerant [Functional Concept]
Processing 00000000.tx.109: In contrast, all treatment groups maintained blood glucose levels not significantly different from those at the inception of therapy (Table 1). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "all treatment groups maintained blood glucose levels"
Meta Candidates (Total=18; Excluded=9; Pruned=0; Remaining=9)
   861   C0428554:blood glucose levels [Laboratory or Test Result]
   858   C0596197:treatment blood [Therapeutic or Preventive Procedure]
   827   C0005802:Blood Glucose [Carbohydrate]
   827   C0428548:glucose levels [Laboratory or Test Result]
   799   C0005767:Blood [Tissue]
   799   C0005768:blood [Body Substance]
   799   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   799   C0229664:Blood [Body Substance]
   799   C0441889:Levels [Qualitative Concept]
   793 E C0337438:glucose level [Laboratory Procedure]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
   727 E C0333275:Bloody [Qualitative Concept]
   716 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   716 E C0392895:Bloods [Population Group]
   716 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   716 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "not significantly different from those at the inception of therapy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.110: In the IGT animals, glucose levels were higher after 10 weeks in all treatment groups, with the striking exception of the linomide plus rhReg group (Table 1), in which the mean blood glucose levels did not deteriorate (rhReg plus linomide vs. control, P < 0.0005). 

Phrase: "In the IGT animals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0003062:Animals [Animal]
   756   C0271650:Impaired glucose tolerance [Disease or Syndrome]

Phrase: "glucose levels"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0428548:glucose levels [Laboratory or Test Result]
   966 E C0337438:glucose level [Laboratory Procedure]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "higher after 10 weeks"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in all treatment groups,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705169:Treatment [Conceptual Entity]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "with the striking exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1554961:exception [Idea or Concept]
   861   C1705847:Exception [Conceptual Entity]

Phrase: "of the linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "plus rhReg group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0683626:human group [Population Group]
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "in which"

Phrase: "the mean blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "deteriorate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184513:deteriorate [Finding]

Phrase: "(rhReg plus linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "vs. control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "P < 0.0005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.111: IPGTT determinations were performed before and after the 10-week treatment period in glucose-intolerant mice. 

Phrase: "IPGTT determinations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0680730:determinations [Governmental or Regulatory Activity]
   771 E C1148554:determination [Laboratory Procedure]
   717   C0017741:Glucose tolerance test [Diagnostic Procedure]

Phrase: "were"

Phrase: "performed before"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0884358:Performed [Functional Concept]
   799 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and after the 10-week treatment period"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C0332174:/week [Temporal Concept]
   748   C0439230:week [Temporal Concept]
   748   C0439531:/period [Temporal Concept]
   748   C1515981:And [Idea or Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C1948053:Period [Temporal Concept]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "in glucose-intolerant mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
Processing 00000000.tx.112: In the control group, all animals succumbed to diabetes. 

Phrase: "In the control group,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "all animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "succumbed to diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.113: In the Reg-treated (Reg alone and Reg plus linomide) groups, 6 of 10 animals who did not progress to frank diabetes had no deterioration of glucose tolerance at 24 weeks [blood glucose: 0 min values (mean  SEM), 8.2  2 and 7.9  2.7 mmol/liter; 

Phrase: "In the Reg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "(Reg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "and"

Phrase: "Reg plus linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "6 of 10 animals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0439187:/10^6 [Quantitative Concept]
   819   C1881839:10^6 [Quantitative Concept]
   770   C0003062:Animals [Animal]

Phrase: "who"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "frank"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "had"

Phrase: "no deterioration of glucose tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0868945:Deterioration [Phenomenon or Process]

Phrase: "at 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "[blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "0 min values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "(mean  SEM"

Phrase: ")"

Phrase: ","

Phrase: "8.2  2"

Phrase: "and"

Phrase: "7.9  2.7 mmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0475211:liter [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.114: 60 min values, 15.3  6.2 and 10.2  2.4 mmol/liter at 14 and 24 weeks, respectively]. 

Phrase: "60 min values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "15.3  6.2"

Phrase: "and"

Phrase: "10.2  2.4 mmol/liter at 14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0475211:liter [Quantitative Concept]

Phrase: "and"

Phrase: "24 weeks,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "respectively"

Phrase: "]."
Processing 00000000.tx.115: Linomide treatment alone, however, did not confer protection from diabetes in this group. 

Phrase: "Linomide treatment alone, however,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   812   C0039798:treatment [Functional Concept]
   812   C0087111:Treatment [Therapeutic or Preventive Procedure]
   812   C0205171:Alone [Quantitative Concept]
   812   C0439044:alone [Finding]
   812   C0679994:alone [Group Attribute]
   812   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]
   812   C1522326:Treatment [Functional Concept]
   812   C1533734:Treatment [Therapeutic or Preventive Procedure]
   812   C1705169:Treatment [Conceptual Entity]
   812   C3538994:TREATMENT [Research Activity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confer"

Phrase: "protection from diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "in this group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.116: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.117: Blood glucose levels in surviving mice with advanced disease in the various treatment groups before therapy at 10 weeks and after treatment at 24 weeks of age  Five-week-old animal experiments. 

Phrase: "Blood glucose levels in surviving mice"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   833   C0428554:blood glucose levels [Laboratory or Test Result]
   790   C0005802:Blood Glucose [Carbohydrate]
   790   C0428548:glucose levels [Laboratory or Test Result]
   767   C1511225:Mouse Blood [Tissue]
   756 E C0337438:glucose level [Laboratory Procedure]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0229664:Blood [Body Substance]
   753   C0441889:Levels [Qualitative Concept]
   725 E C1511227:Mouse Blood Vessel [Tissue]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "with advanced disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in the various treatment groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705169:Treatment [Conceptual Entity]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "before therapy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039798:therapy [Functional Concept]
  1000   C0087111:Therapy [Therapeutic or Preventive Procedure]
  1000   C1363945:Therapy [Finding]

Phrase: "at 10 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "and after treatment"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   882   C0001758:After-Treatment [Health Care Activity]
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1515981:And [Idea or Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "at 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age  Five-week-old animal experiments."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0205664:Animal Experiments [Research Activity]
   799   C0003062:Animal [Animal]
   799   C0681814:Experiments [Research Activity]
   766 E C1706386:Experiment [Conceptual Entity]
   716 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.118: As in the rhReg-treated mice in the advanced disease experiments, the 80% of rhReg-treated female NOD that remained nondiabetic at 40 weeks of age had, as a group, no deterioration of glucose tolerance (blood glucose: 0 min values, 5.4  0.2 and 5.8  0.2 mmol/liter; 

Phrase: "As in the rhReg-treated mice"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0086418:Human [Human]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C1419333:REG [Gene or Genome]
   744   C1514798:recombinant [Organism]
   744   C1522326:Treated [Functional Concept]
   744   C1705631:REG [Gene or Genome]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "in the advanced disease experiments,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0679246:advanced disease [Finding]

Phrase: "the 80% of rhReg-treated female NOD"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   762   C0043210:Human, Female [Population Group]
           female
   742   C0015780:Female [Finding]
   742   C0085243:NOD [Mammal]
   742   C0086287:female [Population Group]
   742   C0086418:Human [Human]
   742   C0332293:treated [Therapeutic or Preventive Procedure]
   742   C0751781:NOD [Disease or Syndrome]
   742   C1419333:REG [Gene or Genome]
   742   C1514798:recombinant [Organism]
   742   C1522326:Treated [Functional Concept]
   742   C1705497:Female [Qualitative Concept]
   742   C1705498:Female [Qualitative Concept]
   742   C1705631:REG [Gene or Genome]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "that remained nondiabetic at 40 weeks of age"

Phrase: "had"

Phrase: ","

Phrase: "as"

Phrase: "a group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "no deterioration of glucose tolerance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0868945:Deterioration [Phenomenon or Process]

Phrase: "(blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "0 min values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "5.4  0.2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5.8  0.2 mmol/liter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0475211:liter [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.119: 60 min values, 5.9  0.1 and 6.4  0.3 mmol/liter at 6 and 41 weeks of age, respectively). 

Phrase: "60 min values,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "5.9  0.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6.4  0.3 mmol/liter at 6"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0475211:liter [Quantitative Concept]

Phrase: "and"

Phrase: "41 weeks of age,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.120: Effects of the various treatments on pancreatic -cell area, islet -cell area, and islet mononuclear infiltrate At 24 weeks of age, visible islet -cells were present in 14 of 23 animals that were glucose tolerant at the beginning of the treatment period (groups ad, NGT), but in only 2 of 16 mice that were initially glucose-intolerant (groups ad, IGT). 

Phrase: "Effects of the various treatments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   764   C1518681:Treatment Effect [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on pancreatic -cell area,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: "islet -cell area,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]
   734   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   734   C1522529:Islet Cell [Cell]

Phrase: "and"

Phrase: "islet mononuclear infiltrate At 24 weeks of age,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332448:Infiltrate [Pathologic Function]
   744   C1546677:Infiltrate [Intellectual Product]
   744   C1549537:Infiltrate [Functional Concept]

Phrase: "visible islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "present in 14 of 23 animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]

Phrase: "that"

Phrase: "were"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "tolerant at the beginning of the treatment period"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0231198:Tolerant [Functional Concept]

Phrase: "(groups ad,"

Phrase: "NGT"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "but in only 2 of 16 mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0025914:Mice [Mammal]
   748   C0025929:mice [Mammal]
   748   C0026809:Mice [Mammal]
   748   C0205171:Only [Quantitative Concept]
   748   C0233535:but [Mental or Behavioral Dysfunction]
   748   C1720467:Only [Intellectual Product]

Phrase: "that"

Phrase: "were"

Phrase: "initially glucose-intolerant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0231200:Intolerant [Functional Concept]

Phrase: "(groups ad,"

Phrase: "IGT"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: ")."
Processing 00000000.tx.121: There was no significant difference in islet size between the groups, and the -cell area in the islets (-cell area per islet) was variable (groups ad: NGT range, 00.7 m2; 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in islet size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1268722:Difference in size [Finding]
           size difference
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between the groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "the -cell area in the islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017446:Area [Geographic Area]
   753   C0205146:Area [Spatial Concept]

Phrase: "(-cell area per islet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "was"

Phrase: "variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "(groups ad"

Phrase: ":"

Phrase: "NGT range,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0086715:Normal Range [Quantitative Concept]
   812   C1514721:Range [Quantitative Concept]
   812   C2348147:Range [Quantitative Concept]
   812   C3542016:Range [Intellectual Product]

Phrase: "00.7 m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0457242:m2 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.122: n = 23; 

Phrase: "n = 23"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C0450348:23 [Quantitative Concept]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.123: groups ad: IGT, 0.0750.792 m2; 

Phrase: "groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "ad"

Phrase: ":"

Phrase: "IGT,"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0271650:Impaired glucose tolerance [Disease or Syndrome]
   901   C0178665:Glucose tolerance [Physiologic Function]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0220929:tolerance [Mental Process]
   827   C0221099:Impaired [Functional Concept]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0684336:Impaired [Pathologic Function]
   827   C1704410:Tolerance [Qualitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: "0.0750.792 m2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0457242:m2 [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.124: n = 16). 

Phrase: "n = 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.125: Treatment with linomide, rhReg, or both agents together did not alter the morphological characteristics of the islets (infiltrate area per islet area, -cell per islet area) in the initially glucose-intolerant mice (Table 2). 

Phrase: "Treatment with linomide,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "rhReg,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "or"

Phrase: "both agents together"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the morphological characteristics of the islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1521970:Characteristics [Qualitative Concept]

Phrase: "(infiltrate area per islet area, -"

Phrase: "cell per islet area"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   819   C1522529:Islet Cell [Cell]
   770   C0007634:Cell [Cell]
   770   C1269647:Cell [Cell]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "in the initially glucose-intolerant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.126: However, combined treatment with linomide and rhReg caused a 3-fold increase in the mean -cell area per islet in group d (NGT) compared with that in the untreated controls (P < 0.05), and a trend toward a higher -cell area was also noted in group b (NGT) treated with rhReg only (Table 2). 

Phrase: "However,"

Phrase: "combined treatment with linomide"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0009429:combined treatment [Therapeutic or Preventive Procedure]
   833   C1704537:Combined Treatment [Therapeutic or Preventive Procedure]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "and"

Phrase: "rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a 3-fold increase in the mean -cell area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "per islet"

Phrase: "in group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "d ("

Phrase: "NGT"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: ")"

Phrase: "compared with that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "in the untreated controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0332155:untreated [Finding]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "(P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a trend toward a higher -cell area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1521798:trend [Temporal Concept]

Phrase: "was"

Phrase: "also"

Phrase: "noted in group b"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0441833:Group [Idea or Concept]
   770   C0687744:group [Population Group]
   770   C1257890:Group [Population Group]
   770   C1552516:Group [Health Care Related Organization]
   770   C1705428:Group [Conceptual Entity]
   770   C1705429:Group [Population Group]
   737   C1316572:Note [Clinical Attribute]
   737   C1317574:Note [Intellectual Product]
   737   C1369612:Note [Clinical Attribute]

Phrase: "(NGT"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   901   C0178665:Glucose tolerance [Physiologic Function]
   901   C0860800:normal glucose [Finding]
   827   C0013220:Tolerance [Finding]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0020963:Tolerance [Pathologic Function]
   827   C0205307:Normal [Qualitative Concept]
   827   C0220929:tolerance [Mental Process]
   827   C0231197:Tolerance [Physiologic Function]
   827   C0439166:% normal [Quantitative Concept]
   827   C1704410:Tolerance [Qualitative Concept]
   827   C2347086:% Normal [Quantitative Concept]
   771 E C0680282:toleration [Social Behavior]
   755 E C0231198:Tolerant [Functional Concept]

Phrase: ")"

Phrase: "treated with rhReg only"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0086418:Human [Human]
   753   C0205171:Only [Quantitative Concept]
   753   C1419333:REG [Gene or Genome]
   753   C1514798:recombinant [Organism]
   753   C1522326:Treated [Functional Concept]
   753   C1705631:REG [Gene or Genome]
   753   C1720467:Only [Intellectual Product]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.127: In the prediabetic animals, a significant augmentation of -cell area was seen in animals at 21 and 40 weeks of age (Table 2). 

Phrase: "In the prediabetic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "a significant augmentation of -cell area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017446:Area [Geographic Area]
   804   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "seen in animals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0003062:Animals [Animal]
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "at 21"

Phrase: "and"

Phrase: "40 weeks of age (Table 2"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0439230:weeks [Temporal Concept]
   719 E C0332174:/week [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.128: The appropriate control group for the treated animals at age 40 weeks is made up of frankly diabetic animals (in which -cell area is nil; data not shown), as all female NOD mice develop diabetes by this age. 

Phrase: "The appropriate control group for the treated animals"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   770   C0009932:Control Group [Group]
   750   C1511501:Control Animal [Animal]
   750   C1642385:Animal group [Group]
   744   C0243148:control [Qualitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1550141:Control [Substance]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]
   744   C1882979:Control [Conceptual Entity]
   744   C2587213:Control [Functional Concept]
   744   C3274648:Control [Qualitative Concept]

Phrase: "at age 40 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439230:weeks [Temporal Concept]
   793 E C0332174:/week [Temporal Concept]

Phrase: "is"

Phrase: "made up of frankly diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1881534:Make [Functional Concept]

Phrase: "("

Phrase: "in which -cell area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017446:Area [Geographic Area]
   861   C0205146:Area [Spatial Concept]

Phrase: "is"

Phrase: "nil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442734:Nil [Quantitative Concept]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "all female NOD mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0085243:Mice, NOD [Mammal]
           NOD
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0751781:NOD [Disease or Syndrome]

Phrase: "develop"

Phrase: "diabetes by this age."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.129: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.130: Morphometric characteristics of the islets of female NOD mice in the various treatment groups at the end of the experiments  Pancreatic IRI content Determinations of pancreatic IRI content (nanomoles per g wet wt) were obtained from representative animals in the advanced disease group at 24 weeks of age. 

Phrase: "Morphometric characteristics of the islets of female NOD mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "in the various treatment groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705169:Treatment [Conceptual Entity]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the experiments  Pancreatic IRI content Determinations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0680730:determinations [Governmental or Regulatory Activity]
   766 E C1148554:determination [Laboratory Procedure]

Phrase: "of pancreatic IRI content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]

Phrase: "(nanomoles per g wet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439191:Nanomole [Quantitative Concept]

Phrase: "wt)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "were"

Phrase: "obtained from representative animals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0003062:Animals [Animal]
   770   C1301820:Obtained [Functional Concept]
   770   C1882932:Representative [Activity]
   737 E C1706701:Obtain [Activity]

Phrase: "in the advanced disease group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   734   C0679246:advanced disease [Finding]

Phrase: "at 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]
Processing 00000000.tx.131: In the NGT mice, pancreatic IRI content in the treatment groups did not differ from that in the surviving control mice. 

Phrase: "In the NGT mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "pancreatic IRI content in the treatment groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "differ from that"

Phrase: "in the surviving control mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.132: However, comparison to IRI content of diabetic control animals (reflecting IRI in control animals that succumbed to diabetes by 24 weeks of age) revealed a markedly augmented content in the treatment groups (Fig. 4). 

Phrase: "However,"

Phrase: "comparison to IRI content of diabetic control animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707455:Comparison [Activity]

Phrase: "("

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "IRI in control animals"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "that"

Phrase: "succumbed to diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]

Phrase: "by 24 weeks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439230:weeks [Temporal Concept]
   827 E C0332174:/week [Temporal Concept]

Phrase: "of age)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a markedly augmented content in the treatment groups"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0423896:Content [Mental Process]
   744   C0456205:Content [Conceptual Entity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.133: In the IGT mice, however, the IRI content was very low in control mice that survived until 24 weeks, as was the content in the linomide-treated mice (Fig. 4). 

Phrase: "In the IGT mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   756   C0271650:Impaired glucose tolerance [Disease or Syndrome]

Phrase: "however,"

Phrase: "the IRI content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "very low in control mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0442811:Very low [Finding]
   760   C0205251:low [Qualitative Concept]
   760   C1299352:Low [Qualitative Concept]
   760   C1550472:low [Idea or Concept]

Phrase: "that"

Phrase: "survived until 24 weeks,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0439230:weeks [Temporal Concept]
   737   C0310255:SURVIVE [Pharmacologic Substance]
   737 E C0332174:/week [Temporal Concept]

Phrase: "as"

Phrase: "was"

Phrase: "the content in the linomide-treated mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.134: In rhReg-treated IGT mice, IRI content, although quite variable, was considerably higher, on the average, (rhReg vs. linomide, P < 0.04; rhReg plus linomide vs. linomide, P < 0.04; Fig. 4). 

Phrase: "In rhReg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "IGT mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   756   C0271650:Impaired glucose tolerance [Disease or Syndrome]

Phrase: "IRI content,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]

Phrase: "although"

Phrase: "quite variable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "was"

Phrase: "considerably higher,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "on the average,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "(rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "vs. linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "P < 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; rhReg plus linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "vs. linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "P < 0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "; Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.135: In the 5-week-old prediabetic mice treated with rhReg alone (Fig. 3), pancreatic IRI at 41 weeks of age was augmented in seven of nine animals and was similar to that in nondiabetic male NOD mice (Fig. 4). 

Phrase: "In the 5-week-old prediabetic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "treated with rhReg"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0086418:Human [Human]
   760   C1419333:REG [Gene or Genome]
   760   C1514798:recombinant [Organism]
   760   C1522326:Treated [Functional Concept]
   760   C1705631:REG [Gene or Genome]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "pancreatic IRI at 41 weeks of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]

Phrase: "was"

Phrase: "augmented in seven of nine animals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0003062:Animals [Animal]
   753   C0205217:Augmented [Quantitative Concept]
   753   C0205453:Seven [Quantitative Concept]
   753   C0205455:Nine [Quantitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "in nondiabetic male NOD mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0085243:Mice, NOD [Mammal]
           NOD
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0751781:NOD [Disease or Syndrome]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.136: View larger version (12K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.137: Pancreatic IRI content at 24 and 41 weeks of age in the advanced disease and prediabetic treatment groups, respectively. 

Phrase: "Pancreatic IRI content at 24"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "and"

Phrase: "41 weeks of age"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0439230:weeks [Temporal Concept]
   737 E C0332174:/week [Temporal Concept]

Phrase: "in the advanced disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "prediabetic treatment groups,"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1552516:Group [Health Care Related Organization]
   827   C1552839:groups [Idea or Concept]
   827   C1705169:Treatment [Conceptual Entity]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "respectively."
Processing 00000000.tx.138: fNOD 14 wks, Animals with advanced disease; 

Phrase: "fNOD 14 wks,"

Phrase: "Animals with advanced disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0003047:animals disease [Disease or Syndrome]
   770   C0003062:Animals [Animal]

Phrase: ";"
Processing 00000000.tx.139: fNOD 5 wks, prediabetic animals. 

Phrase: "fNOD 5 wks,"

Phrase: "prediabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.140: Each filled circle represents an individual animal; 

Phrase: "Each filled circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1282913:Circle [Spatial Concept]
   861   C1551714:Circle [Population Group]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an individual animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]

Phrase: ";"
Processing 00000000.tx.141: horizontal lines show mean group values. 

Phrase: "horizontal lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mean group values."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]
Processing 00000000.tx.142: The first two scattergrams on the left show reference values of nondiabetic 8-week-old male NOD mice (mNOD) and age-matched diabetic female NOD mice with glucosuria (fNOD [diab.]).   

Phrase: "The first two scattergrams on the left"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "reference values of nondiabetic 8-week-old male NOD mice"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086715:Reference Values [Quantitative Concept]
   739   C0042295:Values [Qualitative Concept]
   739   C1514811:Reference [Idea or Concept]
   739   C1706462:Reference [Conceptual Entity]
   706 E C1522609:Value [Quantitative Concept]

Phrase: "(mNOD"

Phrase: ")"

Phrase: "and"

Phrase: "age-matched diabetic female NOD mice with glucosuria"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0085243:Mice, NOD [Mammal]
           NOD
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0751781:NOD [Disease or Syndrome]

Phrase: "(fNOD"

Phrase: "[diab."

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.143: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  In the present study, we show that in female NOD mice with advanced disease, the combination of rhReg protein injections combined with immunomodulation by linomide, but not each modality separately, results in a significant salvage rate of glucose-intolerant mice from diabetes, with a concomitant preservation of pancreatic insulin stores. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In the present study,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C2985663:Study Reference [Intellectual Product]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1514811:Reference [Idea or Concept]
   760   C1706462:Reference [Conceptual Entity]
   760   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that in female NOD mice"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0085243:Mice, NOD [Mammal]
           NOD
   760   C0015780:Female [Finding]
   760   C0025914:Mice [Mammal]
   760   C0025929:mice [Mammal]
   760   C0026809:Mice [Mammal]
   760   C0043210:female [Population Group]
   760   C0086287:female [Population Group]
   760   C0751781:NOD [Disease or Syndrome]
   760   C1705497:Female [Qualitative Concept]
   760   C1705498:Female [Qualitative Concept]

Phrase: "with advanced disease,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the combination of rhReg protein injections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205195:Combination [Qualitative Concept]
   744   C1947911:Combination [Physical Object]

Phrase: "combined with immunomodulation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205195:Combined [Qualitative Concept]
   790   C0678889:Immunomodulation [Organism Function]
   790   C1963758:Immunomodulation [Therapeutic or Preventive Procedure]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "by linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "each modality separately,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0695347:Modality [Idea or Concept]
   861   C1547664:Modality [Diagnostic Procedure]

Phrase: "results in a significant salvage rate of glucose-intolerant mice"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   739   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   739   C0025914:Mice [Mammal]
   739   C0025929:mice [Mammal]
   739   C0026809:Mice [Mammal]
   739   C0085405:SALVAGE [Therapeutic or Preventive Procedure]
   739   C0231200:Intolerant [Functional Concept]
   739   C0237881:significant [Quantitative Concept]
   739   C0442967:Salvage [Therapeutic or Preventive Procedure]
   739   C0750502:Significant [Idea or Concept]
   739   C0871208:Rate [Activity]
   739   C1274040:Result [Functional Concept]
   739   C1521828:Rate [Quantitative Concept]
   739   C1546471:Result [Idea or Concept]
   739   C1546944:Significant [Qualitative Concept]
   739   C2825142:Result [Finding]

Phrase: "from diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "with a concomitant preservation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033085:Preservation [Laboratory Procedure]
   861   C1514402:Preservation [Laboratory Procedure]

Phrase: "of pancreatic insulin stores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1698986:Store [Functional Concept]
Processing 00000000.tx.144: In this group, rhReg-induced pancreatic IRI augmentation alone did not confer protection from diabetes, as was observed in the glucose-tolerant group. 

Phrase: "In this group,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "rhReg-induced pancreatic IRI augmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1293122:Augmentation [Therapeutic or Preventive Procedure]
   711   C1533581:Recombinant Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confer"

Phrase: "protection from diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "as"

Phrase: "was"

Phrase: "observed in the glucose-tolerant group."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0231198:Tolerant [Functional Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1441672:Observed [Functional Concept]
   753   C1552516:Group [Health Care Related Organization]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]
Processing 00000000.tx.145: As linomide down-regulates IL-1 and TNF secretion by NOD splenic macrophages (Weiss, L., I. Reibstein, M. Zeira, S. Slavin, and D. J. Gross, manuscript in preparation), it is likely that linomide-induced down-regulation of these and possibly other cytokines that have been shown to adversely affect -cell function (17, 18, 19) and/or insulin action (20, 21) underlies the improved metabolic outcome with the combined therapy. 

Phrase: "As linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "down-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   805   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805   C2626739:Lanugo [Eukaryote]

Phrase: "IL-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0021755:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0600251:IL1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "and"

Phrase: "TNF secretion by NOD splenic macrophages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "(Weiss,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "I. Reibstein,"

Phrase: "M. Zeira,"

Phrase: "S. Slavin,"

Phrase: "and"

Phrase: "D. J. Gross, manuscript in preparation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that linomide-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "down-regulation of these"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "other cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to adversely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0007613:Cell Function [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1705273:Function [Intellectual Product]
   861   C1948049:Cell [Spatial Concept]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(17,"

Phrase: "18,"

Phrase: "19"

Phrase: ")"

Phrase: "and/or"

Phrase: "insulin action"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0441472:Action [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C3266814:Action [Activity]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(20,"

Phrase: "21"

Phrase: ")"

Phrase: "underlies"

Phrase: "the improved metabolic outcome with the combined therapy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1518681:Therapy Outcome [Finding]
   744   C1274040:Outcome [Functional Concept]
Processing 00000000.tx.146: The lack of visible preservation of -cell area in the glucose-intolerant group probably results from the paucity of islets in the examined pancreata and the small number of animals available for analysis. 

Phrase: "The lack of visible preservation of -cell area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0332268:lack [Qualitative Concept]

Phrase: "in the glucose-intolerant group probably"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0441833:Group [Idea or Concept]
   812   C0687744:group [Population Group]
   812   C1257890:Group [Population Group]
   812   C1552516:Group [Health Care Related Organization]
   812   C1705428:Group [Conceptual Entity]
   812   C1705429:Group [Population Group]

Phrase: "results from the paucity of islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "in the examined pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   827   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the small number of animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "available for analysis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0470187:Available [Functional Concept]
Processing 00000000.tx.147: In glucose-tolerant 14-week-old animals and 5-week-old prediabetic mice, preservation of -cell area was apparent with rhReg treatment alone. 

Phrase: "In glucose-tolerant 14-week-old animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "5-week-old prediabetic mice,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "preservation of -cell area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017446:Area [Geographic Area]
   812   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "apparent with rhReg treatment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "alone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]
Processing 00000000.tx.148: Thus, in animals with less severe disease, rhReg-induced -cell augmentation might override the destructive autoimmune process and prevent clinical diabetes. 

Phrase: "Thus,"

Phrase: "in animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "with less severe disease,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "rhReg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell augmentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "might"

Phrase: "override"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547671:Over-ride [Activity]

Phrase: "the destructive autoimmune process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0443146:Autoimmune Process [Pathologic Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "and"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "clinical diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.149: As modulation of -cell mass has been shown to determine the susceptibility of NOD mice to autoimmune diabetes (22), it is conceivable that Reg acts via -cell mass-dependent modulation of autoimmunity. 

Phrase: "As modulation of -cell mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the susceptibility of NOD mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0012655:Susceptibility [Clinical Attribute]
   760   C0220898:Susceptibility [Organism Attribute]
   760   C1264642:Susceptibility [Functional Concept]
   760   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to autoimmune diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "it"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that Reg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "via -cell mass-dependent modulation of autoimmunity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.150: The presence of insulitis in the majority of rhReg-treated animals, however, would suggest a more direct effect of Reg on -cell mass. 

Phrase: "The presence of insulitis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the majority"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680220:majority [Social Behavior]

Phrase: "of rhReg-treated animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003062:Animals [Animal]

Phrase: "however,"

Phrase: "would"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "direct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439851:Direct [Qualitative Concept]
  1000   C1947931:Direct [Qualitative Concept]

Phrase: "effect of Reg on -cell mass."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.151: Reg is a C-type lectin originally cloned from a complementary DNA library prepared from regenerating islets (23). 

Phrase: "Reg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "is"

Phrase: "a C-type lectin originally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0023206:Lectin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cloned from a complementary DNA library"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0006556:DNA, Complementary [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C0872147:DNA Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
           Library
   753   C0009013:cloned [Cell]
   753   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0023621:Library [Manufactured Object,Organization]
   753   C0751608:Library [Gene or Genome,Nucleic Acid, Nucleoside, or Nucleotide]
   719 E C1522642:Clone [Tissue]

Phrase: "prepared from regenerating islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0334213:regenerating [Functional Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: As Reg is also expressed in pancreatic acinar tissue and is identical to pancreatic stone protein and thread protein, its role in -cell neogenesis/replication has remained controversial. 

Phrase: "As Reg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "is"

Phrase: "also"

Phrase: "expressed in pancreatic acinar tissue"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0227578:Pancreatic acinus [Body Part, Organ, or Organ Component]
   770   C1280423:Pancreatic acinus [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C0040300:Tissue [Tissue]
   760   C0332207:Acinar [Spatial Concept]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "is"

Phrase: "identical to pancreatic stone protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205280:Identical [Qualitative Concept]

Phrase: "and"

Phrase: "thread protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "its role in -cell neogenesis/replication"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   853   C0007590:cell replication [Cell Function]
   804   C0598312:Replication [Genetic Function]
   804   C1883725:replication [Qualitative Concept]
   733 E C0205173:Replicate [Functional Concept]
   733 E C0205341:Replicate [Functional Concept]

Phrase: "has"

Phrase: "remained controversial."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0680243:controversies [Social Behavior]
Processing 00000000.tx.153: In a study by Miyaura et al., Reg expression appears to positively correlate -cell replication in the insulinoma-implanted NEDH (New England-Deaconess Hospital) rat model (24). 

Phrase: "In a study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "by Miyaura et al.,"

Phrase: "Reg expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to positively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "correlate -"

Phrase: "cell replication in the insulinoma-implanted NEDH"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0007590:cell replication [Cell Function]
   748   C0598312:Replication [Genetic Function]
   748   C1883725:replication [Qualitative Concept]

Phrase: "(New England-Deaconess Hospital"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: ")"

Phrase: "rat model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.154: On the other hand, Smith and co-workers found no such relationship in rats either partially pancreatectomized or glucose infused, both of which are known to induce -cell replication (25). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "co-workers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0024752:workers [Functional Concept]
   861   C1306056:workers [Occupation or Discipline]
   861   C1527116:Workers [Population Group]

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no such relationship in rats either partially"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "pancreatectomized"

Phrase: "or"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "infused"

Phrase: ","

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell replication"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0007590:cell replication [Cell Function]
   861   C0598312:Replication [Genetic Function]
   861   C1883725:replication [Qualitative Concept]
   789 E C0205173:Replicate [Functional Concept]
   789 E C0205341:Replicate [Functional Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.155: Both groups failed to demonstrate Reg expression in pancreatic islets or -cell lines; 

Phrase: "Both groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "Reg expression in pancreatic islets or -cell lines"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: ";"
Processing 00000000.tx.156: in contrast, studies by others demonstrated Reg at both the protein and messenger RNA levels in replicating islets (26, 27, 28) and islets of remission in BB/Wor/Tky rats (29). 

Phrase: "in contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "studies by others"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0557651:Study [Manufactured Object]
   790   C0947630:studies [Laboratory Procedure]
   790   C1955473:Others [Finding]
   790   C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "Reg at both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1419333:REG [Gene or Genome]
   790   C1705631:REG [Gene or Genome]

Phrase: "the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "messenger RNA levels in replicating islets"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "(26,"

Phrase: "27,"

Phrase: "28"

Phrase: ")"

Phrase: "and"

Phrase: "islets of remission"

Phrase: "in BB/Wor/Tky rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034699:Rats, BB [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.157: Adopting the protocol of Watanabe et al. 

Phrase: "Adopting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0425382:adopting [Finding]

Phrase: "the protocol of Watanabe et al."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0965970:ET protocol [Therapeutic or Preventive Procedure]
   753   C0442711:Protocol [Intellectual Product]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.158: (14) for amelioration of diabetes in pancreatectomized rats, we found that rhReg ameliorates diabetes in female NOD mice, providing that the autoimmune process is adequately controlled. 

Phrase: "(14"

Phrase: ")"

Phrase: "for amelioration"

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "in pancreatectomized rats,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that rhReg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "ameliorates"

Phrase: "diabetes in female NOD mice,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: "providing that"

Phrase: "the autoimmune process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0443146:Autoimmune Process [Pathologic Function]
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "is"

Phrase: "adequately"

Phrase: "controlled."
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C2587213:Controlled [Functional Concept]
   966 E C0243148:control [Qualitative Concept]
   966 E C1550141:Control [Substance]
   966 E C1882979:Control [Conceptual Entity]
   966 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.159: We also found a concurrent increase in islet -cell area, possibly a result of Reg-induced maturation of NOD islet -cell precursors (6). 

Phrase: "We also"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "a concurrent increase in islet -cell area,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "a result of Reg-induced maturation of NOD islet -cell precursors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   738   C1274040:Result [Functional Concept]
   738   C1546471:Result [Idea or Concept]
   738   C2825142:Result [Finding]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.160: Although not examined directly, the presence of the increased -cell area in rhReg-treated, but not in linomide-treated, animals and the direct demonstration of Reg-induced -cell proliferation in rat islets (14) lend credence to our interpretation. 

Phrase: "Although"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "directly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947931:Directly [Qualitative Concept]

Phrase: "the presence of the increased -cell area"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in rhReg-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1419333:REG [Gene or Genome]
   827   C1705631:REG [Gene or Genome]

Phrase: "treated,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "but"

Phrase: "not in linomide-treated, animals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0003062:Animals [Animal]
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]
   760   C1518422:Not [Functional Concept]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "the direct demonstration of Reg-"

Phrase: "induced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "cell proliferation in rat islets"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0596290:Cell Proliferation [Cell Function]
   797   C0022131:cell islets [Body Part, Organ, or Organ Component]
   781 E C1522529:Islet Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0334094:Proliferation [Pathologic Function]
   760   C1269647:Cell [Cell]
   760   C1514485:Proliferation [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(14"

Phrase: ")"

Phrase: "lend"

Phrase: "credence to our interpretation."
Processing 00000000.tx.161: Interestingly, endogenous expression of pancreatic Reg messenger RNA correlates with islet neogenesis in the Syrian golden hamster islet regeneration model (30) and more recently in an analogous model for rat islet regeneration (31). 

Phrase: "Interestingly,"

Phrase: "endogenous expression of pancreatic Reg messenger RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0040649:RNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "correlates with islet neogenesis"

Phrase: "in the Syrian golden hamster islet regeneration model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C3161035:Model [Intellectual Product]

Phrase: "(30"

Phrase: ")"

Phrase: "and"

Phrase: "more recently in an analogous model"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205172:More [Functional Concept]
   753   C0332185:Recently [Temporal Concept]
   753   C3161035:Model [Intellectual Product]

Phrase: "for rat islet regeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: Reg has also recently been shown to have a mitogenic effect on a ductular pancreatic cell line (32), a potential source of -cell neogenesis (4). 

Phrase: "Reg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "has"

Phrase: "also recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "a mitogenic effect on a ductular pancreatic cell line"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "a potential source of -cell neogenesis"

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.163: These observations together with the finding that pancreatic Reg expression correlates with a reduced severity of the disease in the NOD mouse with active diabetogenesis (33) indicate that Reg could conceivably mediate cross-talk between the exocrine and endocrine pancreas under conditions where induction of -cell mass expansion is needed. 

Phrase: "These observations together with the finding"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0302523:observations [Research Activity]
   753   C0700325:observations [Health Care Activity]
   753   C3244290:observations [Functional Concept]
   719 E C1964257:Observation [Diagnostic Procedure]

Phrase: "that pancreatic Reg expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "correlates with a reduced severity of the disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0521117:disease severity [Qualitative Concept]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0392756:Reduced [Qualitative Concept]
   744   C0439793:Severity [Qualitative Concept]
   744   C2983285:Severity [Intellectual Product]

Phrase: "in the NOD mouse"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085243:Mouse, NOD [Mammal]
           NOD
   861   C0025914:Mouse [Mammal]
   861   C0025929:mouse [Mammal]
   861   C0026809:Mouse [Mammal]
   861   C0751781:NOD [Disease or Syndrome]

Phrase: "with active diabetogenesis"

Phrase: "(33"

Phrase: ")"

Phrase: "indicate"

Phrase: "that Reg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1419333:REG [Gene or Genome]
  1000   C1705631:REG [Gene or Genome]

Phrase: "could"

Phrase: "conceivably"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "cross-talk between the exocrine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0010357:Crosstalk [Molecular Function]
   806   C2986468:Cross-talk [Cell Function]
   760   C0037817:Talk [Organism Function]
   760   C0234856:talk [Daily or Recreational Activity]
   760   C0600118:talk [Finding]
   760   C2828360:Cross [Conceptual Entity]

Phrase: "and"

Phrase: "endocrine pancreas under conditions where induction of -cell mass expansion"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   777   C1522529:Endocrine pancreas cell [Cell]
   775   C0877425:Mass of pancreas [Finding]
           mass pancreas
   760   C0022131:Pancreas, Endocrine [Body Part, Organ, or Organ Component]
   760   C1283884:Endocrine pancreas [Body Part, Organ, or Organ Component]
   757   C0229525:Endocrine cell [Cell]
   757   C3155662:pancreas induction [Biologic Function]
   739   C0014136:Endocrine [Body System]
   739   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   739   C0521425:Endocrine [Functional Concept]
   739   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "needed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]
Processing 00000000.tx.164: Linomide, the immunomodulating agent used in this study, has pleotropic effects on the immune system (12) and appears to abrogate diabetes in the NOD mouse by reinduction of tolerance to self antigens without general immunosuppression (12). 

Phrase: "Linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "the immunomodulating agent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005525:Immunomodulating Agent [Immunologic Factor,Pharmacologic Substance]
   861   C0450442:Agent [Chemical Viewed Functionally]
   861   C1254351:Agent [Pharmacologic Substance]
   861   C1521826:Agent [Intellectual Product]

Phrase: "used in this study,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "has"

Phrase: "pleotropic effects on the immune system"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "abrogate"

Phrase: "diabetes in the NOD mouse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]

Phrase: "by reinduction"

Phrase: "of tolerance"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0013220:Tolerance [Finding]
  1000   C0020963:Tolerance [Pathologic Function]
  1000   C0220929:tolerance [Mental Process]
  1000   C0231197:Tolerance [Physiologic Function]
  1000   C1704410:Tolerance [Qualitative Concept]
   944 E C0680282:toleration [Social Behavior]
   928 E C0231198:Tolerant [Functional Concept]

Phrase: "to self antigens"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0004359:Self-Antigens [Immunologic Factor]
   861   C0003320:Antigens [Immunologic Factor]
   861   C0036588:Self [Idea or Concept]
   861   C1551994:self [Intellectual Product]
   861   C3244295:Self [Intellectual Product]
   755 E C2698667:ANTIGENICITY [Regulation or Law]

Phrase: "without general immunosuppression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0021079:Immunosuppression [Therapeutic or Preventive Procedure]
   861   C0021080:Immunosuppression [Organism Function]
   861   C1373218:Immunosuppression [Pathologic Function]

Phrase: "(12"

Phrase: ")."
Processing 00000000.tx.165: A disturbing effect of linomide observed in this study was the appearance of marked peritoneal adhesions in the groups treated with the combination of Reg and linomide. 

Phrase: "A disturbing effect of linomide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "observed in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1441672:Observed [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "the appearance of marked peritoneal adhesions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0233426:Appearance [Organism Attribute]
   753   C0700364:Appearance [Qualitative Concept]

Phrase: "in the groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "treated with the combination of Reg"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0205195:Combination [Qualitative Concept]
   753   C1419333:REG [Gene or Genome]
   753   C1522326:Treated [Functional Concept]
   753   C1705631:REG [Gene or Genome]
   753   C1947911:Combination [Physical Object]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "linomide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.166: In these groups, deaths unrelated to diabetes occurred and obliged us to terminate the experiments earlier than originally planned. 

Phrase: "In these groups,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "deaths"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:deaths [Organism Function]
  1000   C1306577:DEATHS [Finding]

Phrase: "unrelated to diabetes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0445356:Unrelated [Finding]
   790   C1704623:Unrelated [Qualitative Concept]
   718 E C0680208:unrelatedness [Social Behavior]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "obliged"

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "terminate"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "the experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "earlier than originally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1279919:Early [Temporal Concept]

Phrase: "planned."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1301732:Planned [Functional Concept]
   966 E C0270724:PLAN [Disease or Syndrome]
Processing 00000000.tx.167: This mortality was probably due to the peritoneal pathology and could be a result of the proinflammatory effect of linomide observed in some experimental settings, such as collagen-induced arthritis (34, 35). 

Phrase: "This mortality"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026565:Mortality [Quantitative Concept]
  1000   C0026566:mortality [Quantitative Concept]

Phrase: "was"

Phrase: "probably due to the peritoneal pathology"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0030664:Pathology [Biomedical Occupation or Discipline]
   753   C0031153:Peritoneal [Body Part, Organ, or Organ Component]
   753   C0205469:pathology [Functional Concept]
   753   C0442034:peritoneal [Body Location or Region]
   753   C0677042:pathology [Pathologic Function]
   753   C0750492:Probably [Idea or Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "a result of the proinflammatory effect of linomide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1274040:Result [Functional Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "observed in some experimental settings,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1441672:Observed [Functional Concept]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0542559:setting [Functional Concept]
   726   C1318139:{Setting} [Quantitative Concept]

Phrase: "such as collagen-induced arthritis"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0971858:Arthritis, Collagen-Induced [Experimental Model of Disease]
           Collagen Arthritis
   827   C0003864:Arthritis [Disease or Syndrome]
   827   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   827   C0205263:Induced [Functional Concept]
   827   C1167364:collagen [Cell Component]
   755 E C0439689:Collagenous [Qualitative Concept]
   734 E C0018099:Gout [Disease or Syndrome]

Phrase: "(34,"

Phrase: "35"

Phrase: ")."
Processing 00000000.tx.168: We are currently examining alternative modalities of rhReg administration to avoid this complication. 

Phrase: "We"

Phrase: "are"

Phrase: "currently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521116:Currently [Temporal Concept]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "alternative modalities of rhReg administration to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0695347:modalities [Idea or Concept]
   711 E C1547664:Modality [Diagnostic Procedure]

Phrase: "avoid"

Phrase: "this complication."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009566:Complication [Pathologic Function]
  1000   C2362589:Complication [Idea or Concept]
   928 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.169: In conclusion, we have demonstrated that abrogation of autoimmunity combined with induction of expansion/maintenance of -cell mass constitutes a potential therapeutic approach for treatment of IDDM. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that abrogation of autoimmunity"

Phrase: "combined with induction of expansion/maintenance of -cell mass"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   762   C0007595:cell expansion [Cell Function]
   762   C1516348:Cell Maintenance [Cell Function]
   742   C0007634:Cell [Cell]
   742   C0024501:Maintenance [Activity]
   742   C0205195:Combined [Qualitative Concept]
   742   C0205263:Induction [Functional Concept]
   742   C0577559:Mass [Finding]
   742   C0857127:induction [Therapeutic or Preventive Procedure]
   742   C1269647:Cell [Cell]
   742   C1306372:*Mass [Quantitative Concept]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]
   742   C3152252:Mass [Quantitative Concept]
   708 E C0336789:Combine [Manufactured Object]

Phrase: "constitutes"

Phrase: "a potential therapeutic approach for treatment of IDDM."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.170: The exact nature of both linomide-induced immunomodulation and Reg-induced expansion of -cell mass in the NOD mouse remains to be determined.  

Phrase: "The exact nature of both linomide-induced immunomodulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]

Phrase: "and"

Phrase: "Reg-induced expansion of -cell mass in the NOD mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0577559:Mass [Finding]
   739   C1306372:*Mass [Quantitative Concept]
   739   C3152252:Mass [Quantitative Concept]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "determined."
Processing 00000000.tx.171: Acknowledgments  We are grateful to Britta Laub for excellent technical assistance.  

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Britta Laub"

Phrase: "for excellent technical assistance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0018896:Assistance [Social Behavior]
   827   C0449851:Technical [Functional Concept]
Processing 00000000.tx.172: Footnotes  1 This work was supported by grants from the Juvenile Diabetes Foundation International (to D.J.G. and S.S.), the Wellcome Trust, UK (to A.C.), and the Bayer and Pfizer Co. 

Phrase: "Footnotes  1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Juvenile Diabetes Foundation"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   734   C0011854:Juvenile Diabetes [Disease or Syndrome]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: "("

Phrase: "to D.J.G."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0439417:d g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "and S."

Phrase: "S."

Phrase: ")"

Phrase: ","

Phrase: "the Wellcome Trust,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237935:Trust [Individual Behavior]
   861   C3245466:trust [Idea or Concept]

Phrase: "UK"

Phrase: "("

Phrase: "to A.C."

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the Bayer"

Phrase: "and"

Phrase: "Pfizer Co."
Processing 00000000.tx.173: (to J.v.d.B. during his study leave at Oxford). 

Phrase: "("

Phrase: "to J.v.d.B."

Phrase: "during his study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "leave at Oxford"

Phrase: ")."
Processing 00000000.tx.174: Received October 1, 1997.  

Phrase: "Received October 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "1997."
Processing 00000000.tx.175: References Top Abstract Introduction Materials and Methods Results Discussion References  Gepts W 1957 Contribution a ltude morphologique des lots de Langerhans au cours du diabte. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Gepts W 1957 Contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1880177:Contribution [Activity]

Phrase: "a ltude morphologique des lots de Langerhans au cours du diabte."
Processing 00000000.tx.176: Ann Soc R Sci Med Nat Brux 10:105108 Gepts W 1965 Pathological anatomy of the pancreas in juvenile diabetes mellitus. 

Phrase: "Ann Soc R Sci Med Nat"

Phrase: "Brux"

Phrase: "10"

Phrase: ":"

Phrase: "105108 Gepts W 1965 Pathological anatomy of the pancreas"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0002808:Anatomy [Biomedical Occupation or Discipline]
   742   C0030664:Pathological [Biomedical Occupation or Discipline]
   742   C0700276:anatomy [Anatomical Structure]
   742   C1384516:anatomy [Qualitative Concept]
   742   C1521733:Pathological [Functional Concept]

Phrase: "in juvenile diabetes mellitus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0011854:juvenile diabetes mellitus [Disease or Syndrome]
           Juvenile Diabetes
   901   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C3146221:Juvenile [Age Group]
Processing 00000000.tx.177: Diabetes 14:619633[Medline] Gepts W, Lecompte PM 1981 The pancreatic islets in diabetes. 

Phrase: "Diabetes 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "619633"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gepts W,"

Phrase: "Lecompte PM 1981"

Phrase: "The pancreatic islets in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.178: Am J Med 70:105115[Medline] Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE 1993 A second pathway for regeneration of the adult exocrine and endocrine pancreas. 

Phrase: "Am"

Phrase: "J Med 70"

Phrase: ":"

Phrase: "105115"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bonner-Weir S,"

Phrase: "Baxter LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Schuppin GT,"

Phrase: "Smith FE 1993"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0554249:Smith [Professional or Occupational Group]
   827   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "A second pathway for regeneration of the adult"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0682673:second pathway [Body Part, Organ, or Organ Component]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: "exocrine"

Phrase: "and"

Phrase: "endocrine pancreas."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0022131:Pancreas, Endocrine [Body Part, Organ, or Organ Component]
  1000   C1283884:Endocrine pancreas [Body Part, Organ, or Organ Component]
   861   C0014136:Endocrine [Body System]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C0521425:Endocrine [Functional Concept]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.179: A possible recapitulation of embryonic development. 

Phrase: "A possible recapitulation of embryonic development."
Processing 00000000.tx.180: Diabetes 42:17151720[Abstract] Gu D, Sarvetnick N 1993 Epithelial cell proliferation and islet neogenesis in IFN- transgenic mice. 

Phrase: "Diabetes 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "17151720"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Gu D,"

Phrase: "Sarvetnick N 1993 Epithelial cell proliferation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1326341:Epithelial Cell Proliferation [Cell Function]
   839   C0334097:Epithelial proliferation [Pathologic Function]
   827   C0596290:Cell Proliferation [Cell Function]
   799   C0334094:Proliferation [Pathologic Function]
   799   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "islet neogenesis in IFN- transgenic mice."
Processing 00000000.tx.181: Development 118:3346[Abstract/Free FullText] Fernandes A, King LC, Guz Y, Stein R, Wright CVE, Teitelman G 1997 Differentiation of new insulin producing cells is induced by injury in adult pancreatic islets. 

Phrase: "Development 118"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "3346"

Phrase: "[Abstract/Free FullText"

Phrase: "] Fernandes A,"

Phrase: "King"

Phrase: "LC,"

Phrase: "Guz Y,"

Phrase: "Stein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wright CVE,"

Phrase: "Teitelman G 1997 Differentiation of new insulin producing cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C0007589:cells differentiation [Cell Function]
           Differentiation
   742   C1511938:Differentiation [Clinical Attribute]
   742   C2945687:Differentiation [Functional Concept]

Phrase: "is"

Phrase: "induced by injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205263:Induced [Functional Concept]
   790   C3263722:Injury [Injury or Poisoning]
   790   C3263723:Injury [Injury or Poisoning]

Phrase: "in adult pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.182: Endocrinology 138:17501762[Abstract/Free FullText] OReilly LA, Gu D, Sarvetnick N, Edlund H, Phillips JM, Fulford T, Cooke A 1997 -Cell neogenesis in an animal model of IDDM. 

Phrase: "Endocrinology 138"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "17501762"

Phrase: "[Abstract/Free FullText"

Phrase: "] OReilly LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Gu D,"

Phrase: "Sarvetnick N,"

Phrase: "Edlund H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Phillips JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Fulford T,"

Phrase: "Cooke"

Phrase: "A 1997 -Cell neogenesis in an animal model"

Phrase: "of IDDM."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.183: Diabetes 46:599606[Abstract] Landin Olsson M, Palmer JP, Lernmark A, Blom L, Sundkvist G, Nystrom L, Dahlquist G 1992 Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly-diagnosed diabetic and matched control children. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "599606"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Landin Olsson M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Palmer JP,"

Phrase: "Lernmark A,"

Phrase: "Blom L,"

Phrase: "Sundkvist G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Nystrom L,"

Phrase: "Dahlquist G 1992 Predictive value of islet cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1514307:Predictive Value [Qualitative Concept]
   744   C0681890:predictive [Qualitative Concept]
   744   C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   829   C0011854:Insulin-Dependent Diabetes Mellitus 1 [Disease or Syndrome]
           Diabetes Mellitus, Insulin-Dependent
           Insulin Dependent Diabetes
   762   C0457592:Insulin type [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C1275890:autoantibodies insulin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "in a population-based study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709599:Population Based Study [Research Activity]
   913   C0681876:Population Study [Research Activity]
   827   C0557651:Study [Manufactured Object]
   827   C2603343:Study [Research Activity]

Phrase: "of newly-diagnosed diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0241863:DIABETIC [Finding]
   734   C1518321:Newly Diagnosed [Qualitative Concept]

Phrase: "and"

Phrase: "matched control children."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008059:Children [Age Group]
   827   C0680063:Children [Family Group]
Processing 00000000.tx.184: Diabetologia 35:10681073[Medline] Levy Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P 1992 Islet cell antibodies in normal French schoolchildren. 

Phrase: "Diabetologia 35"

Phrase: ":"

Phrase: "10681073"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levy Marchal C,"

Phrase: "Tichet J,"

Phrase: "Fajardy I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gu XF,"

Phrase: "Dubois F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Czernichow P 1992 Islet cell antibodies in normal French schoolchildren."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   775   C0063900:antibodies cell islet [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   760   C1522529:Islet Cell [Cell]
   757   C0007634:Normal cell [Cell]
           Cell
   757   C1268443:Normal cell [Cell]
   739   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C1269647:Cell [Cell]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   706 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.185: Diabetologia 35:577582[Medline] Samuelsson U, Ludvigsson J, Sundkvist G 1994 Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM. 

Phrase: "Diabetologia 35"

Phrase: ":"

Phrase: "577582"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Samuelsson U,"

Phrase: "Ludvigsson J,"

Phrase: "Sundkvist G 1994 Islet cell antibodies (ICA),"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   859   C0369247:G Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858   C0524983:G cell [Cell]
   827   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   827   C0063900:islet cell antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C1522529:Islet Cell [Cell]
   799   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   799   C0007634:Cell [Cell]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
   766 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "insulin autoantibodies (IAA),"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   966   C1275890:Insulin autoantibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0004358:Autoantibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "islet cell surface antibodies (ICSA)"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0124026:islet cell surface antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   906   C0063900:islet cell antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   861   C0699040:Cell surface [Cell Component]
   861   C1522529:Islet Cell [Cell]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0007634:Cell [Cell]
   812   C0205148:Surface [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "C-peptide in 1031 school children"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0006558:C-Peptide [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   783 E C0071642:peptide C [Amino Acid, Peptide, or Protein]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in a population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "with a high background incidence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0021149:Incidence [Quantitative Concept]
   827   C0220856:incidence [Functional Concept]
   755 E C1551358:incident [Idea or Concept]

Phrase: "of IDDM."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0011854:Diabetes Mellitus, Insulin-Dependent [Disease or Syndrome]
           Insulin Dependent Diabetes
   861   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   812   C0011847:Diabetes [Disease or Syndrome]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   812   C1701901:Dependent [Qualitative Concept]
   812   C3244310:dependent [Functional Concept]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.186: Diabetes Res Clin Pract 26:155162[Medline] Marks JB, Skyler JS 1991 Immunotherapy of type I diabetes mellitus. 

Phrase: "Diabetes Res Clin Pract 26"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0011847:Diabetes [Disease or Syndrome]
   804   C0011849:Diabetes [Disease or Syndrome]
   804   C1315013:CLIN [Intellectual Product]
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "155162"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marks JB,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550751:JB [Temporal Concept]

Phrase: "Skyler JS 1991 Immunotherapy of type I diabetes mellitus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0021083:Immunotherapy [Therapeutic or Preventive Procedure]
Processing 00000000.tx.187: J Clin Endocrinol Metab 72:39[Medline] Gross DJ, Sidi H, Weiss L, Kalland T, Rosenmann E, Slavin S 1994 Prevention of diabetes mellitus in non-obese diabetic mice by linomide, a novel immunomodulating drug. 

Phrase: "J Clin Endocrinol Metab 72"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1315013:CLIN [Intellectual Product]

Phrase: ":"

Phrase: "39"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gross DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Sidi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Weiss L,"

Phrase: "Kalland T,"

Phrase: "Rosenmann E,"

Phrase: "Slavin S 1994 Prevention of diabetes mellitus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C1659987:diabetes prevention [Educational Activity]
   748   C0199176:Prevention [Therapeutic or Preventive Procedure]
   748   C1706420:PREVENTION [Research Activity]
   748   C2700409:prevention [Qualitative Concept]

Phrase: "in non-obese diabetic mice"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0085243:Non-Obese Diabetic Mice [Mammal]
   886   C1513853:NON Mouse [Mammal]
   875   C0025933:Mice, Obese [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0028754:Obese [Disease or Syndrome]
   812   C0241863:DIABETIC [Finding]
   812   C1518422:Non [Functional Concept]

Phrase: "by linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "a novel immunomodulating drug."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]
Processing 00000000.tx.188: Diabetologia 37:11951201[CrossRef][Medline] Slavin S, Weiss L, Wenlang X, Gross DJ 1996 Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide). 

Phrase: "Diabetologia 37"

Phrase: ":"

Phrase: "11951201"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Slavin S,"

Phrase: "Weiss L,"

Phrase: "Wenlang X,"

Phrase: "Gross DJ 1996 Successful treatment of diabetes"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0521982:successful treatment [Clinical Attribute]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C3538994:TREATMENT [Research Activity]
   743 E C0679864:success treatment [Qualitative Concept]

Phrase: "in NOD mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0085243:Mice, NOD [Mammal]
           NOD
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
   861   C0751781:NOD [Disease or Syndrome]

Phrase: "with advanced disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0679246:advanced disease [Finding]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "by islet isografts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392763:Isografts [Tissue]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "immunoregulation with Linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0678889:Immunoregulation [Organism Function]

Phrase: "(quinoline-3-carboxamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2716460:quinoline-3-carboxamide [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.189: Cell Transplant 5:627630[CrossRef][Medline] Watanabe T, Yonemura Y, Yonekura H, Suzuki Y, Miyashita H, Sugiyama K, Moriizumi S, Unno M, Tanaka O, Kondo H, Bone AJ, Takasawa S, Okamoto H 1994 Pancreatic -cell replication and amelioration of surgical diabetes by Reg protein. 

Phrase: "Cell Transplant 5"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0206152:Transplant, Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0040732:Transplant [Therapeutic or Preventive Procedure]
   827   C0332835:Transplant [Tissue]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "627630"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Watanabe T,"

Phrase: "Yonemura Y,"

Phrase: "Yonekura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Suzuki Y,"

Phrase: "Miyashita H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sugiyama K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Moriizumi S,"

Phrase: "Unno M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tanaka O,"

Phrase: "Kondo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bone AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Takasawa S,"

Phrase: "Okamoto H 1994 Pancreatic -cell replication"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0007590:cell replication [Cell Function]
   799   C0598312:Replication [Genetic Function]
   799   C1883725:replication [Qualitative Concept]
   727 E C0205173:Replicate [Functional Concept]
   727 E C0205341:Replicate [Functional Concept]

Phrase: "and"

Phrase: "amelioration of surgical diabetes"

Phrase: "by Reg protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.190: Proc Natl Acad Sci USA 91:35893592[Abstract] Barr KA, Hopkins SA, Sreekrishna K 1992 Protocol for efficient secretion of HSA developed from Pichia pastoris. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "35893592"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barr KA,"

Phrase: "Hopkins SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Sreekrishna K 1992 Protocol for efficient secretion of HSA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0442711:Protocol [Intellectual Product]
   742   C1507394:Protocol [Intellectual Product]
   742   C1522729:Protocol [Intellectual Product]
   742   C2348563:Protocol [Intellectual Product]

Phrase: "developed from Pichia pastoris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0031874:Pichia [Fungus]
Processing 00000000.tx.191: Pharm Eng 12:4851 Gross DJ, Leibowitz G, Cerasi E, Kaiser N 1996 Increased susceptibility of islets from diabetes-prone Psammomys obesus to the deleterious effects of chronic glucose exposure. 

Phrase: "Pharm Eng 12"

Phrase: ":"

Phrase: "4851 Gross DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012836:DJ [Geographic Area]

Phrase: "Leibowitz G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Cerasi E,"

Phrase: "Kaiser N 1996 Increased susceptibility of islets"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0012655:Susceptibility [Clinical Attribute]
   748   C0220898:Susceptibility [Organism Attribute]
   748   C1264642:Susceptibility [Functional Concept]
   748   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "from diabetes-prone Psammomys obesus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1013768:Psammomys obesus [Mammal]
   812   C0033783:Psammomys [Mammal]

Phrase: "to the deleterious effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "of chronic glucose exposure."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
Processing 00000000.tx.192: Endocrinology 137:56105615[Abstract] Comens PG, Wolf BA, Unanue ER, Lacy PE, McDaniel ML 1987 Interleukin 1 is a potent modulator of insulin secretion from isolated rat islets of Langerhans. 

Phrase: "Endocrinology 137"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "56105615"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Comens PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "Wolf BA,"

Phrase: "Unanue ER,"

Phrase: "Lacy PE,"

Phrase: "McDaniel ML 1987 Interleukin 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   840   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "a potent modulator of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709060:Modulator [Manufactured Object]

Phrase: "from isolated rat islets"

Phrase: "of Langerhans."
Processing 00000000.tx.193: Diabetes 36:963970[Abstract] Southern C, Schulster D, Green IC 1990 Inhibition of insulin secretion by interleukin-1 and tumor necrosis factor-alpha by an L-arginine-dependent nitric oxide generating syetem. 

Phrase: "Diabetes 36"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "963970"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Southern C,"

Phrase: "Schulster D,"

Phrase: "Green IC 1990 Inhibition of insulin secretion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C2250323:inhibition of insulin secretion [Cell Function]
   804   C2259158:inhibition of secretion [Cell Function]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by interleukin-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   861   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor necrosis factor-alpha"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
  1000   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
  1000   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
  1000   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   923   C1323304:tumor necrosis factor [Molecular Function]
   861   C0333516:Tumor necrosis [Neoplastic Process]
   812   C0027540:Necrosis [Organ or Tissue Function]
   812   C0027651:Tumor [Neoplastic Process]
   812   C0439095:Alpha [Intellectual Product]
   812   C1334928:Necrosis [Finding]
   812   C1521761:Factor [Functional Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C2003941:Alpha [Intellectual Product]
   812   C2350010:Alpha [Qualitative Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3273930:Tumor [Finding]

Phrase: "by an L-arginine-dependent nitric oxide generating syetem."
Processing 00000000.tx.194: FEBS Lett 276:4244[CrossRef][Medline] Mehta VK, Hao W, Brooks-Worrell BM, Palmer JP 1994 Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression. 

Phrase: "FEBS Lett 276"

Phrase: ":"

Phrase: "4244"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mehta VK,"

Phrase: "Hao W,"

Phrase: "Brooks-Worrell BM,"

Phrase: "Palmer JP 1994 Low-dose interleukin 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   877   C1422482:JP-1 [Gene or Genome]
   818   C0021755:Interleukin-1 [Amino Acid, Peptide, or Protein,Immunologic Factor]
   818   C1522428:Interleukin 1 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0021764:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C1527200:Interleukin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor necrosis factor individually"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   923   C1323304:tumor necrosis factor [Molecular Function]
   923   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0333516:Tumor necrosis [Neoplastic Process]
   812   C0027540:Necrosis [Organ or Tissue Function]
   812   C0027651:Tumor [Neoplastic Process]
   812   C1334928:Necrosis [Finding]
   812   C1521761:Factor [Functional Concept]
   812   C1578706:Tumor [Intellectual Product]
   812   C2827422:Factor [Conceptual Entity]
   812   C3273930:Tumor [Finding]

Phrase: "stimulate"

Phrase: "insulin release"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0030685:Release [Health Care Activity]
   861   C0391871:Release [Functional Concept]
   861   C0439180:% release [Quantitative Concept]
   861   C0680255:release [Health Care Activity]
   861   C1283071:Release [Functional Concept]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   861   C1963578:Release [Therapeutic or Preventive Procedure]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "but in combination cause suppression."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0015127:cause [Functional Concept]
   760   C0205195:Combination [Qualitative Concept]
   760   C0221103:Suppression [Pathologic Function]
   760   C0233535:but [Mental or Behavioral Dysfunction]
   760   C0301625:Suppression [Organism Function]
   760   C0439181:% suppression [Quantitative Concept]
   760   C0728721:suppression [Mental Process]
   760   C1524003:Cause [Conceptual Entity]
   760   C1947911:Combination [Physical Object]
Processing 00000000.tx.195: Eur J Endocrinol 130:208214[Medline] Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM 1994 Tumor necrosis factor alpha inhibits signaling from the insulin receptor. 

Phrase: "Eur J Endocrinol 130"

Phrase: ":"

Phrase: "208214"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hotamisligil GS,"

Phrase: "Murray DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Choy LN,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0861352:LN [Neoplastic Process]
   861   C1428884:ln [Gene or Genome]

Phrase: "Spiegelman BM 1994 Tumor necrosis factor alpha"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   877   C0041368:tumor necrosis factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           tumor necrosis factor
   877   C1168005:Tumor Necrosis Factor alpha [Laboratory Procedure]
   877   C1456820:Tumor Necrosis Factor-alpha [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Tumour necrosis factor
   845   C1323304:tumor necrosis factor [Molecular Function]
   818   C0333516:Tumor necrosis [Neoplastic Process]
   795   C0027540:Necrosis [Organ or Tissue Function]
   795   C0027651:Tumor [Neoplastic Process]
   795   C0439095:Alpha [Intellectual Product]
   795   C1334928:Necrosis [Finding]
   795   C1521761:Factor [Functional Concept]
   795   C1578706:Tumor [Intellectual Product]
   795   C2003941:Alpha [Intellectual Product]
   795   C2350010:Alpha [Qualitative Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C3273930:Tumor [Finding]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "signaling from the insulin receptor."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1514762:Receptor Signaling [Molecular Function]
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]
Processing 00000000.tx.196: Proc Natl Acad Sci USA 91:48544858[Abstract] Miles PD, Romeo OM, Higo K, Cohen A, Rafaat K, Olefsky JM 1997 TNF--induced insulin resistance in vivo and its prevention by troglitazone. 

Phrase: "Proc Natl Acad Sci USA 91"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "48544858"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Miles PD,"

Phrase: "Romeo OM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028971:OM [Geographic Area]
   861   C1705272:OM [Idea or Concept]

Phrase: "Higo K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cohen A,"

Phrase: "Rafaat K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Olefsky JM 1997 TNF--induced insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   818   C0021655:Insulin Resistance [Pathologic Function]
   818   C2700570:INSULIN RESISTANCE [Gene or Genome]
   795   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C0237834:Resistance [Mental Process]
   795   C1514892:Resistance [Physiologic Function]
   795   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   795   C1579433:Insulin [Pharmacologic Substance]
   740 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   724 E C0332325:Resistant [Functional Concept]
   724 E C1550464:resistent [Idea or Concept]
   724 E C2827757:RESISTANT [Laboratory or Test Result]
   712 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "its prevention by troglitazone."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]
Processing 00000000.tx.197: Diabetes 46:16781683[Abstract] Itoh A, Maki T 1996 Protection of nonobese diabetic mice from autoimmune diabetes by reduction of islet mass before insulitis. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "16781683"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Itoh A,"

Phrase: "Maki T 1996 Protection of nonobese diabetic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1545588:Protection [Finding]

Phrase: "from autoimmune diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: "by reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "of islet mass"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]
   861   C3152252:Mass [Quantitative Concept]

Phrase: "before insulitis."
Processing 00000000.tx.198: Proc Natl Acad Sci USA 93:1105311056[Abstract/Free FullText] Terazono K, Yamamoto H, Takasawa S, K. 

Phrase: "Proc Natl Acad Sci USA 93"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "1105311056"

Phrase: "[Abstract/Free FullText"

Phrase: "] Terazono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yamamoto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Takasawa S,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.199: S, Yonemura Y, Tochino Y, Okamoto H 1988 A novel gene activated in regenerating islets. 

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "Yonemura Y,"

Phrase: "Tochino Y,"

Phrase: "Okamoto H 1988"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "A novel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "activated in regenerating islets."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0334213:regenerating [Functional Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.200: J Biol Chem 263:21112114[Abstract/Free FullText] Miyaura C, Chen L, Appel M, Alam T, Inman L, Hughes SD, Milburn JL, Unger RH, Newgard CB 1991 Expression of reg/PSP, a pancreatic exocrine gene: relationship to changes in islet -cell mass. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "21112114"

Phrase: "[Abstract/Free FullText"

Phrase: "] Miyaura C,"

Phrase: "Chen L,"

Phrase: "Appel M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Alam T,"

Phrase: "Inman L,"

Phrase: "Hughes SD,"

Phrase: "Milburn JL,"

Phrase: "Unger RH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035493:Rh [Element, Ion, or Isotope]
   861   C2699077:Rh- [Classification]
   861   C2699078:Rh+ [Classification]

Phrase: "Newgard CB 1991 Expression of reg/PSP,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "a pancreatic exocrine gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017337:Gene [Gene or Genome]

Phrase: ":"

Phrase: "relationship to changes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439849:Relationship [Qualitative Concept]
   790   C1705630:Relationship [Idea or Concept]
   790   C1706279:Relationship [Idea or Concept]
   790   C3540605:Relationship [Intellectual Product]

Phrase: "in islet -cell mass."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]
   734   C0022131:Islet cell [Body Part, Organ, or Organ Component]
   734   C1522529:Islet Cell [Cell]
Processing 00000000.tx.201: Mol Endocrinol 5:226234[Abstract] Smith FE, Bonner Weir S, Leahy JL, Laufgraben MJ, Ogawa Y, Rosen KM, Villa-Komaroff L 1994 Pancreatic Reg/pancreatic stone protein (PSP) gene expression does not correlate with -cell growth and regeneration in rats. 

Phrase: "Mol Endocrinol 5"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "226234"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Smith FE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: "Bonner Weir S,"

Phrase: "Leahy JL,"

Phrase: "Laufgraben MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Ogawa Y,"

Phrase: "Rosen KM,"

Phrase: "Villa-Komaroff L 1994 Pancreatic Reg/pancreatic stone protein (PSP) gene expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   809   C1171362:protein expression [Genetic Function]
   801   C0017262:Gene Expression [Genetic Function]
   801   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0017337:Gene [Gene or Genome]
   788   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "correlate with -cell growth"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0007595:Cell Growth [Cell Function]
   770   C0007634:Cell [Cell]
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1269647:Cell [Cell]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2911660:Growth [Activity]

Phrase: "and"

Phrase: "regeneration in rats."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034963:Regeneration [Organ or Tissue Function]
Processing 00000000.tx.202: Diabetologia 37:994999[CrossRef][Medline] Terazono K, Uchiyama Y, Ide M, Watanabe T, Yonekura H, Yamamoto H, Okamoto H 1990 Expression of reg protein in rat regenerating islets and its co-localization with insulin in the beta cell secretory granules. 

Phrase: "Diabetologia 37"

Phrase: ":"

Phrase: "994999"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Terazono K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Uchiyama Y,"

Phrase: "Ide M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Watanabe T,"

Phrase: "Yonekura H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yamamoto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Okamoto H 1990 Expression of reg protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat regenerating islets"

Phrase: "and"

Phrase: "its co-localization with insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "in the beta cell secretory granules."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0886515:Secretory Granules [Cell Component]
   858   C0010837:Cell granule [Cell Component]
           Granules
   827 E C3271154:Secretory Granule [Cell Component]
   812   C0993609:Granules [Biomedical or Dental Material]
   812   C1327616:Secretory [Cell Function]
   729 E C0205248:Granular [Qualitative Concept]
Processing 00000000.tx.203: Diabetologia 33:250252[Medline] Francis PJ, Southgate JL, Wilkin TJ, Bone AJ 1992 Expression of an islet regenerating (reg) gene in isolated rat islets: effects of nutrient and non-nutrient growth factors. 

Phrase: "Diabetologia 33"

Phrase: ":"

Phrase: "250252"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Francis PJ,"

Phrase: "Southgate JL,"

Phrase: "Wilkin TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Bone AJ 1992 Expression of an islet regenerating (reg) gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0017262:Gene Expression [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in isolated rat islets"

Phrase: ":"

Phrase: "effects of nutrient"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1280500:effects [Qualitative Concept]
   756 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "non-nutrient growth factors."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.204: Diabetologia 35:238242[Medline] Otonkoski T, Mally MI, Hayek A 1994 Opposite effects of -cell differentiation and growth on reg expression in human fetal pancreatic cells. 

Phrase: "Diabetologia 35"

Phrase: ":"

Phrase: "238242"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Otonkoski T,"

Phrase: "Mally MI,"

Phrase: "Hayek"

Phrase: "A 1994 Opposite effects of -cell differentiation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0007589:Cell Differentiation [Cell Function]
           Differentiation
   799   C1511938:Differentiation [Clinical Attribute]
   799   C2945687:Differentiation [Functional Concept]
   727 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "growth on reg expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0018270:'growth' NOS [Organism Function]
   770   C0220844:growth [Physiologic Function]
   770   C1621966:Growth [Organ or Tissue Function]
   770   C2911660:Growth [Activity]

Phrase: "in human fetal pancreatic cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   875   C0439170:% fetal cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.205: Diabetes 43:11641166[Abstract] Ishii C, Kawazu S, Tomono S, Ohno T, Shimizu M, Kato N, Fukuda M, Ito Y, Kurihara S, Murata K, Komeda K 1993 Appearance of a regenerating (reg) gene protein in pancreatic islets of remission BB/Wor//Tky rats. 

Phrase: "Diabetes 43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "11641166"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Ishii C,"

Phrase: "Kawazu S,"

Phrase: "Tomono S,"

Phrase: "Ohno T,"

Phrase: "Shimizu M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kato N,"

Phrase: "Fukuda M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ito Y,"

Phrase: "Kurihara S,"

Phrase: "Murata K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Komeda K 1993 Appearance of a regenerating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0233426:Appearance [Organism Attribute]
   748   C0700364:Appearance [Qualitative Concept]

Phrase: "(reg) gene protein in pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0751455:gene protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "of remission BB/Wor//Tky rats."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0034699:Rats, BB [Mammal]
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
Processing 00000000.tx.206: Endocr J 40:269273[Medline] Rafaeloff R, Barlow SW, Rosenberg L, Vinik AI 1995 Expression of Reg gene in the Syrian golden hamster pancreatic islet regeneration model. 

Phrase: "Endocr J 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "269273"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Rafaeloff R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Barlow SW,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1420193:SW [Gene or Genome]
   861   C1832169:SW [Body System]
   861   C3538902:SW [Gene or Genome]

Phrase: "Rosenberg L,"

Phrase: "Vinik AI 1995 Expression of Reg gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0017262:Gene Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the Syrian golden hamster pancreatic islet regeneration model."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C3161035:Model [Intellectual Product]
Processing 00000000.tx.207: Diabetologia 38:906913[CrossRef][Medline] Zenilman ME, Perfetti R, Swinson K, Magnuson T, Shuldiner AR 1996 Pancreatic regeneration (reg) gene expression in a rat model of islet hyperplasia. 

Phrase: "Diabetologia 38"

Phrase: ":"

Phrase: "906913"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zenilman"

Phrase: "ME,"

Phrase: "Perfetti R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Swinson K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Magnuson T,"

Phrase: "Shuldiner AR 1996 Pancreatic regeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "(reg) gene expression in a rat model of islet hyperplasia."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017262:Gene Expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.208: Surgery 119:576584[Medline] Zenilman ME, Magnuson TH, Swinson K, Egan J, Perfetti R, Shuldiner AR 1996 Pancreatic thread protein is mitogenic to pancreatic-derived cells in culture. 

Phrase: "Surgery 119"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0038894:Surgery [Biomedical Occupation or Discipline]
   861   C0038895:surgery [Functional Concept]
   861   C0543467:Surgery [Health Care Activity]

Phrase: ":"

Phrase: "576584"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zenilman"

Phrase: "ME,"

Phrase: "Magnuson TH,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039725:TH [Geographic Area]
   861   C0039738:Th [Element, Ion, or Isotope]
   861   C1420718:TH [Gene or Genome]

Phrase: "Swinson K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Egan J,"

Phrase: "Perfetti R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Shuldiner AR 1996 Pancreatic thread protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0075269:Pancreatic Thread Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1419333:pancreatic thread protein [Gene or Genome]
   799   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C1710394:Thread [Manufactured Object]
   799   C1882475:Thread [Intellectual Product]

Phrase: "is"

Phrase: "mitogenic to pancreatic-derived cells"

Phrase: "in culture."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.209: Gastroenterology 110:12081214[Medline] Baeza NJ, Moriscot CI, Renaud WP, Okamoto H, Figarella CG, Vialettes BH 1996 Pancreatic regenerating gene overexpression in the nonobese diabetic mouse during active diabetogenesis. 

Phrase: "Gastroenterology 110"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "12081214"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baeza NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Moriscot CI,"

Phrase: "Renaud WP,"

Phrase: "Okamoto H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Figarella CG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0054868:CG [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3540479:CG [Gene or Genome]

Phrase: "Vialettes BH 1996 Pancreatic regenerating gene overexpression in the nonobese diabetic mouse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C1514559:Overexpression [Genetic Function]

Phrase: "during active diabetogenesis."
Processing 00000000.tx.210: Diabetes 45:6770[Abstract] Kleinau S, Larsson P, Bjork J, Holmdahl R, Klareskog L 1989 Linomide, a new immunomodulatory drug, shows different effects on homologous vs. heterologous collagen-induced arthritis in rats. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "6770"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kleinau S,"

Phrase: "Larsson P,"

Phrase: "Bjork J,"

Phrase: "Holmdahl R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Klareskog L 1989 Linomide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: "a new immunomodulatory drug,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0013227:Drug [Pharmacologic Substance]
   827   C1254351:Drug [Pharmacologic Substance]
   771 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   771 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   734 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "different effects on homologous"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "vs. heterologous collagen-induced arthritis in rats."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C0971858:Arthritis, Collagen-Induced [Experimental Model of Disease]
           Collagen Arthritis
   748   C0003864:Arthritis [Disease or Syndrome]
   748   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   748   C0205263:Induced [Functional Concept]
   748   C1167364:collagen [Cell Component]
Processing 00000000.tx.211: Clin Exp Immunol 78:138142[Medline] Bjork J, Kleinau S 1989 Paradoxical effects of LS-2616 (linomide) treatment in the type II collagen arthritis model in mice. 

Phrase: "Clin Exp Immunol 78"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1315013:CLIN [Intellectual Product]
   812   C1417055:EXP [Gene or Genome]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "138142"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bjork J,"

Phrase: "Kleinau S 1989 Paradoxical effects of LS-2616"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "(linomide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0950651:Linomide [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "treatment in the type II collagen arthritis model"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0679845:treatment model [Intellectual Product]
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "in mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]
Processing 00000000.tx.212: Agents Actions 27:319321[Medline]

Phrase: "Agents Actions 27"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0441472:actions [Functional Concept]
   793   C0450442:Agent [Chemical Viewed Functionally]
   793   C1254351:Agent [Pharmacologic Substance]
   793   C1521826:Agent [Intellectual Product]
   793 E C3266814:Action [Activity]

Phrase: ":"

Phrase: "319321"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

